Israel Medical Innovation - Israeli-South African Trade, Technology ...
Israel Medical Innovation - Israeli-South African Trade, Technology ...
Israel Medical Innovation - Israeli-South African Trade, Technology ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
www.israelmedicalinnovation.com<br />
Come meet us at hall 16: G40 in
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Page<br />
Contents<br />
3<br />
Table of Contents (By Category)<br />
7<br />
Table of Contents (By Alphabetical Order)<br />
14<br />
Company Profiles<br />
60<br />
Schedule a Meeting<br />
2
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by category) Click on Company’s name for more details<br />
Category<br />
Company<br />
Aesthetics and Dermatology<br />
Cardiovascular and Peripheral Vascular<br />
Diagnostics<br />
Disposables and Implantable<br />
Cnoga<br />
Coolsense<br />
Erika Carmel<br />
Gilco Pharm<br />
Tav Tech Ltd<br />
BSP Biological Signal Processing<br />
Cnoga<br />
Elitar <strong>Medical</strong><br />
HypnoCore<br />
Itamar <strong>Medical</strong><br />
Shina Systems<br />
Sion Biotext <strong>Medical</strong><br />
3QBD<br />
BSP Biological Signal Processing<br />
DYN Diagnostics<br />
Elitar <strong>Medical</strong><br />
Itamar <strong>Medical</strong><br />
Medoc<br />
HypnoCore<br />
Itamar <strong>Medical</strong><br />
Vasa Applied Technologies<br />
Sialo <strong>Technology</strong><br />
Albaad<br />
Beth-El Industreis<br />
Biovo Technologies<br />
ETView<br />
FirstCare<br />
Intromedix<br />
Mizra <strong>Medical</strong><br />
Nava Group<br />
Noam Urim Enterprises<br />
OHK <strong>Medical</strong> Devices<br />
Sion Biotext <strong>Medical</strong><br />
Toefix<br />
Sialo <strong>Technology</strong><br />
Vasa Applied Technologies<br />
Xenolith <strong>Medical</strong><br />
Schedule a Meeting at<br />
Return to Table of Content<br />
3
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by category) Click on Company’s name for more details<br />
Category<br />
Company<br />
E.M.S<br />
General Health<br />
General Surgery<br />
Industrual OEM<br />
Infection Control and Infectious Diseases<br />
Intensive Care<br />
ETView<br />
FirstCare<br />
Flight <strong>Medical</strong><br />
Gilco Pharm<br />
Aerotel<br />
Albaad<br />
Beth-El Industreis<br />
Cnoga<br />
Coolsense<br />
EarlySense<br />
Elitar <strong>Medical</strong><br />
Itamar <strong>Medical</strong><br />
Mizra <strong>Medical</strong><br />
Motorica<br />
Nava Group<br />
ETView<br />
FlowSense<br />
Intromedix<br />
OHK <strong>Medical</strong> Devices<br />
Virtual Ports<br />
Albaad<br />
Noam Urim Enterprises<br />
Albaad<br />
Beth-El Industreis<br />
Hyginex<br />
Mizra <strong>Medical</strong><br />
NanoVibronix<br />
Noam Urim Enterprises<br />
Sion Biotext <strong>Medical</strong><br />
ETView<br />
Flight <strong>Medical</strong><br />
Schedule a Meeting at<br />
Return to Table of Content<br />
4
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by category) Click on Company’s name for more details<br />
Category<br />
Company<br />
Laboratory Equipment<br />
<strong>Medical</strong> and Hospital Equipment<br />
Monitoring<br />
DYN Diagnostics<br />
Aerotel<br />
Beth-El Industreis<br />
Biovo Technologies<br />
Coolsense<br />
Discover <strong>Medical</strong> Devices<br />
DYN Diagnostics<br />
EarlySense<br />
Erika Carmel<br />
Estar <strong>Medical</strong><br />
ETView<br />
Flight <strong>Medical</strong><br />
FlowSense<br />
Hyginex<br />
HypnoCore<br />
IceCure<br />
Intromedix<br />
Kapel-Kal<br />
Medigus<br />
Motorica<br />
NanoVibronix<br />
OHK <strong>Medical</strong> Devices<br />
Polytex Technologies<br />
Q Core <strong>Medical</strong><br />
Sialo <strong>Technology</strong><br />
Tav Tech Ltd<br />
Ultra Rhino-Therm<br />
Virtual Ports<br />
Xenolith <strong>Medical</strong><br />
Cnoga<br />
EarlySense<br />
Elitar <strong>Medical</strong><br />
FlowSense<br />
Hyginex<br />
HypnoCore<br />
Vasa Applied Technologies<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
5
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by category) Click on Company’s name for more details<br />
Category<br />
Company<br />
Neurology and Degenerative Disease<br />
Pharmaceuticals<br />
Respiratory and Pulmonary<br />
Rehabilitation<br />
Robotics<br />
Services<br />
Telemedicine and Healthcare IT<br />
Urology<br />
Wound and Pain Management<br />
Coolsense<br />
Medoc<br />
Motorica<br />
Itamar <strong>Medical</strong><br />
Gilco Pharm<br />
Discover <strong>Medical</strong> Devices<br />
ETView<br />
Itamar <strong>Medical</strong><br />
Flight <strong>Medical</strong><br />
HypnoCore<br />
Erika Carmel<br />
Itamar <strong>Medical</strong><br />
Motorica<br />
DYN Diagnostics<br />
Flight <strong>Medical</strong><br />
Motorica<br />
2P2D Solutions<br />
Arazy Group<br />
2P2D Solutions<br />
Elitar <strong>Medical</strong><br />
HypnoCore<br />
Shina Systems<br />
Mizra <strong>Medical</strong><br />
NanoVibronix<br />
Vasa Applied Technologies<br />
Xenolith <strong>Medical</strong><br />
Erika Carmel<br />
Gilco Pharm<br />
Medoc<br />
NanoVibronix<br />
Sion Biotext <strong>Medical</strong><br />
Schedule a Meeting at<br />
Return to Table of Content<br />
6
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
14<br />
2P2D SOLUTIONS<br />
Telemedicine and Helathcare IT<br />
Services<br />
15<br />
3QBD<br />
Diagnostics<br />
16<br />
Aerotel<br />
General Health<br />
<strong>Medical</strong> and Hospital Equipment<br />
17<br />
Albaad<br />
Disposables and Implantable<br />
General Health<br />
Industrial OEM<br />
Infection Control and Infectious Diseases<br />
18<br />
Arazy Group<br />
Services<br />
19<br />
Beth-El Industries<br />
<strong>Medical</strong> and Hospital Equipment<br />
Infection Control and Infectious Diseases<br />
E.M.S<br />
General Surgery<br />
20<br />
Biovo Technologies<br />
<strong>Medical</strong> and Hospital Equipment<br />
Disposables and Implantable<br />
21<br />
BSP Biological Signal Processing<br />
Diagnostics<br />
Cardiovascular and Peripheral Vascular<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
7
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
22<br />
Cnoga<br />
Monitoring<br />
Cardiovascular and Peripheral Vascular<br />
Diagnostics<br />
General Health<br />
Aesthetics and Dermatology<br />
23<br />
CoolSense <strong>Medical</strong><br />
<strong>Medical</strong> and Hospital Equipment<br />
Aesthetics and Dermatology<br />
General Health<br />
Neurology and Degenerative Diseases<br />
24<br />
Discover <strong>Medical</strong> Devices<br />
<strong>Medical</strong> and Hospital Equipment<br />
Respiratory and Pulmonary<br />
25<br />
DYN Diagnostics<br />
Diagnostics<br />
Robotics<br />
Laboratory Equipment<br />
26<br />
EarlySense<br />
<strong>Medical</strong> and Hospital Equipment<br />
Monitoring<br />
General Health<br />
27<br />
28<br />
Elitar <strong>Medical</strong><br />
Erika Carmel Ltd.<br />
Diagnostics<br />
Monitoring<br />
Telemedicine and Healthcare IT<br />
Cardiovascular and Peripheral Vascular<br />
General Health<br />
Aesthetics and Dermatology<br />
Wound and Pain Management<br />
<strong>Medical</strong> and Hospital Equipment<br />
Rehabilitation<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
8
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
29<br />
Estar <strong>Medical</strong><br />
<strong>Medical</strong> and hospital Equipment<br />
30<br />
ETView<br />
Disposables and Implantable<br />
Intensive Care<br />
General Surgery<br />
Respiratory and Pulmonary<br />
E.M.S<br />
<strong>Medical</strong> and Hospital Equipment<br />
31<br />
First Care Products<br />
Disposables and Implantable<br />
E.M.S<br />
32<br />
Flight <strong>Medical</strong><br />
<strong>Medical</strong> and Hospital Equipment<br />
Rehabilitation<br />
Intensive Care<br />
Respiratory and Pulmonary<br />
E.M.S<br />
33<br />
FlowSense<br />
Monitoring<br />
<strong>Medical</strong> and Hospital Equipment<br />
34<br />
Gilco Pharm<br />
Pharmaceuticals<br />
Aesthetics and Dermatology<br />
E.M.S<br />
Wound and Pain Management<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
9
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
35<br />
Hyginex<br />
Monitoring<br />
Infection Control and Infectious Diseases<br />
<strong>Medical</strong> and Hospital Equipment<br />
36<br />
HypnoCore<br />
Diagnostics<br />
<strong>Medical</strong> and Hospital Equipment<br />
Monitoring<br />
Telemedicine and Helathcare IT<br />
Cardiovascular and Peripheral Vascular<br />
Respiratory and Pulmonary<br />
37<br />
IceCure<br />
<strong>Medical</strong> and Hospital Equipment<br />
38<br />
Intromedix<br />
Disposables and Implantable<br />
<strong>Medical</strong> and Hospital Equipment<br />
General Surgery<br />
39<br />
Itamar <strong>Medical</strong><br />
Diagnostics<br />
Cardiovascular and Peripheral Vascular<br />
General Health<br />
Neurology and Degenerative Diseases<br />
Respiratory and Pulmonary<br />
40<br />
Kapel - kal<br />
<strong>Medical</strong> and Hospital Equipment<br />
41<br />
Medigus<br />
<strong>Medical</strong> and Hospital Equipment<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
10
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
42<br />
Medoc<br />
Diagnostics<br />
Neurology and Degenerative Diseases<br />
Wound and Pain Management<br />
43<br />
Mizra <strong>Medical</strong><br />
Disposables and Implantable<br />
Urology<br />
General Health<br />
Infection Control and Infectious Diseases<br />
44<br />
Motorika <strong>Medical</strong><br />
<strong>Medical</strong> and Hospital Equipment<br />
Robotics<br />
Rehabilitation<br />
Neurology and Degenerative Diseases<br />
General Health<br />
45<br />
NanoVibronix<br />
Urology<br />
Wound and Pain Management<br />
Infection Control and Infectious Diseases<br />
<strong>Medical</strong> and Hospital Equipment<br />
46<br />
Nava Group<br />
Disposables and Implantable<br />
General Health<br />
47<br />
Noam Urim Enterprises<br />
Disposables and Implantable<br />
Industrial OEM<br />
General Health<br />
Infection Control and Infectious Diseases<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
11
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
48<br />
OHK <strong>Medical</strong> Devices<br />
<strong>Medical</strong> and Hospital Equipment<br />
General Surgery<br />
Disposables and Implantable<br />
49<br />
Polytex Technologies<br />
<strong>Medical</strong> and Hospital Equipment<br />
50<br />
Q Core <strong>Medical</strong><br />
<strong>Medical</strong> and Hospital Equipment<br />
51<br />
Shina Systems<br />
Telemedicine and Healthcare IT<br />
Cardiovascular and Peripheral Vascular<br />
52<br />
Sialo <strong>Technology</strong><br />
<strong>Medical</strong> and Hospital Equipment<br />
Diagnostics<br />
Disposables and implantable<br />
53<br />
Sion Biotex <strong>Medical</strong><br />
Disposables and Implantable<br />
Cardiovascular and Peripheral Vascular<br />
Wound and Pain Management<br />
Infection Control and Infectious Diseases<br />
54<br />
TavTech Ltd<br />
<strong>Medical</strong> and Hospital Equipment<br />
Aesthetics and Dermatology<br />
55<br />
Toefix<br />
Disposables and implantable<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
12
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Table of Contents (by alphabetical order)<br />
Page<br />
Company<br />
Category<br />
56<br />
Ultra Rhino-Therm<br />
<strong>Medical</strong> and Hospital Equipment<br />
57<br />
Vasa Applied Technologies<br />
Disposables and implantable<br />
Monitoring<br />
Diagnostic<br />
Urology<br />
58<br />
Virtual Ports<br />
<strong>Medical</strong> and Hospital Equipment<br />
General Surgery<br />
59<br />
Xenolith <strong>Medical</strong><br />
Disposables and implantable<br />
Urology<br />
<strong>Medical</strong> and Hosiptal Equipment<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
13
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
2P2D SOLUTIONS<br />
www.2p2d.com<br />
Category:<br />
Telemedicine and<br />
Healthcare IT<br />
Services<br />
Company Status:<br />
Complete Validation<br />
Study<br />
Company at a Glance<br />
2P2D Solutions Ltd. is a pioneering technology-based company developing unique<br />
solutions for various unmet needs within the healthcare, biotech and pharmaceutical<br />
industries.<br />
2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for<br />
use in clinical drug trials that incorporates a portable, personalized medication dispensing<br />
device using proprietary 2P2D technology.<br />
<strong>Technology</strong> and Product(s)<br />
2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring<br />
system that incorporates a portable medication dispensing device using proprietary<br />
2P2D technology. The system dispenses personalized drug dosages designated for each<br />
specific patient or group of patients. After patient identification has been fully authorized,<br />
according to the designated clinical trial treatment regimen. This exclusive medication<br />
management system, for use in clinical drug trials, ensures unequaled compliance,<br />
accountability and accuracy.<br />
The Company’s telemedicine solution provides:<br />
• Complete and real-time knowledge of the participant’s compliance and adherence to<br />
the trial protocols.<br />
• Reduced overall duration of the clinical trial period.<br />
• Increased participant’s compliance and adherence to the given medication.<br />
• Cost effective solution for clinical trial packaging and drug accountability.<br />
Goal<br />
Objectives: Investment, Strategic Alliances<br />
Target Businesses: CROs, Pharma companies, Hospitals<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
14
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
3QBD<br />
www.3qbd.com<br />
Category:<br />
Diagnostics<br />
Company at a Glance<br />
Located in Arad, <strong>Israel</strong>, 3QBD Ltd. is an ISO certified start up medical device company.<br />
The company has developed the VGTest, is an In-Vitro Molecular Diagnostic (IVD) device<br />
based on Ion Mobility Spectrometry (IMS) which is used currently for detection of Vaginal<br />
Discharge Infections (VDI).<br />
In December 2009 3QBD Ltd. received the European CE mark for the VGTest, a device<br />
capable of detecting and provides a positive/negative indication for Bacterial Vaginosis<br />
(BV), the most prevalent women’s vaginal infection within 60 seconds.<br />
Future development plans for 3QBD include further research into the VDI field, to detect<br />
additional infections and expanding to other diseases like STD and Cancer, to offer rapid,<br />
accurate results. Further expending to other markets like food and livestock.<br />
<strong>Technology</strong> and Product(s)<br />
IMS (Ion Mobility Spectrometry) <strong>Technology</strong><br />
3QBD’s technology is based on the well established and scientifically proven Ion Mobility<br />
Spectrometry (IMS) technology – first used successfully to detect drugs and explosives.<br />
Today IMS is being used to detect presence and type of infection.<br />
Chemical changes in living systems, or degradation of cells after death through<br />
enzymatic and microbial processes, are accompanied by the breakdown of amino-acids<br />
and production of biogenic amines. Pathological conditions in the human body may be<br />
expressed in the formation of biogenic amines, so that elevated levels of biogenic amines<br />
may be indicative of dysfunctions. IMS is a sensitive instrumental technique for detecting<br />
volatile compounds. It is based on measuring the velocity of ions (ion mobility) drifting<br />
through a gas bath under the influence of an electric field.<br />
The Product<br />
The device works by measuring biogenic amines that are present at elevated levels in<br />
infections and diseases and provides a rapid and accurate indication. In the case of the<br />
BV the result is provided within one minute. The VGTest for BV spares the physician from<br />
having to perform the Amsel Test and “whiff tests” of vaginal fluid or spend time waiting<br />
for laboratory Gram Stain results<br />
Goal<br />
Objectives: Distribution for BV, Strategic allaincess, R&D Funding<br />
Target Businesses: Women’s Health professionals, gynecologists, obstetricians, hospitals<br />
and health clinics<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
15
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Aerotel<br />
www.aerotel.co.il<br />
Category:<br />
General Health<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Clinical Trials<br />
Company at a Glance<br />
Aerotel is one of <strong>Israel</strong>’s longest established high tech companies, specializing in the<br />
manufacturing of communication and medical devices. Aerotel is known for being the<br />
first company in <strong>Israel</strong> to develop an interactive voice response (IVR) system as well as the<br />
portable “Hi-Pack” ECG gauge. The company has exported its products internationally to<br />
approximately 40 countries. Its large and diverse customer base includes leading multinational<br />
corporations such as AT&T.<br />
The innovative MDwave system is a revolutionary development in the frequency therapy<br />
field which brings new hope to patients who have been unable to treat themselves by<br />
means of conventional medicine.<br />
Based on extensive experience in offering individualized personal service to patients,<br />
Aerotel has designed the MDwave to provide maximum flexibility and efficiency to meet<br />
each patient’s distinctive requirements. Aerotel experts are continually working to include<br />
the latest Frequency Medicine knowhow, in the MDwave system. This product has been<br />
developed over an eight-year period and is complaint with the following standards: FCC<br />
and CE 60601-1 and 2.<br />
<strong>Technology</strong> and Product(s)<br />
Aerotel Ltd. has developed a breakthrough medical device, known as MDwave, which<br />
restores energy levels and treats chronic and acute conditions through the use of<br />
Frequency Medicine. Recent studies have demonstrated the positive effect of a low<br />
strength electromagnetic field in specific frequencies, on various systems of our body,<br />
demonstrating high efficacy of such treatments.<br />
MDwave is based on creating a low electromagnetic field that impacts the human cell<br />
properties under health and diseased conditions. This field delivers a safe electromagnetic<br />
energy to the human cells, which encourages them to return to proper and balanced<br />
function, and to operate in a healthy and harmonious way. This enables the immune<br />
system to improve its ability to withstand the daily battle against energy-sapping pollutants,<br />
hence increasing the body’s ability to heal itself.<br />
MDwave is a completely safe, compact and easy-to-use device for administering Frequency<br />
Medicine therapy, via an Electromagnetic field. To get started, you simply connect the MDwave<br />
to a computer and choose from an extensive list of treatments the desired routine for your<br />
patient. Once the treatment routine is set, the MDwave operates without a computer.<br />
Goal<br />
Objectives: Searching for distributors<br />
Target Businesses: Distributors<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
16
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Albaad<br />
www.albaad.com<br />
Category:<br />
Disposables and<br />
Implantable<br />
General Health<br />
Industrial OEM<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
Albaad is one of the three leading producers of wipes worldwide. As a fully integrated<br />
converter with production facilities in Germany, US and <strong>Israel</strong>, global R&D, regulatory<br />
suport and engineering teams, Albaad is a preferred contract manufacturing partner for<br />
renowned multinationals and retailers.<br />
We don’t just make wet wipes; we make it our business to know everything there is to<br />
know about them, constantly studying customer needs, market trends and technological<br />
innovations.<br />
<strong>Technology</strong> and Product(s)<br />
Albaad has registered a range of products intended for professional and consumer<br />
healthcare use. Our disinfection products are registered as medical device class 2a (FDA<br />
and EPA where applicable). Production is also ISO 13485 certified.<br />
The range includes several surface and medical device disinfectants, hand hygiene, patient<br />
care and bathing kits, adult incontinence wipes and several consumer solutions including<br />
natural fever relief, jellyfish relief, hemorrhoids relief and antiseptic wipes.<br />
Albaad wipes are one-step ready for use wipes, tailored to meet our customers’ special<br />
needs and requirements. They are made with soft fabrics and impregnated with gentle<br />
yet effective liquids. The wipes are produced and tested according to stringent standards<br />
and inspected by strict quality assurance procedures.<br />
Goal<br />
Objectives: Seeking disinfection liquid customers who wish to find a wipe expert partner<br />
to expand their line with wipes in Europe.<br />
Seeking Private Label manufacturing opportunities for Healthcare distributors in the EU<br />
and worldwide.<br />
Target Businesses: Institutional distributors, disinfection brands and consumer healthcare<br />
brands<br />
Target Countries: EU, worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
17
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Arazy Group<br />
www.arazygroup.com<br />
Category:<br />
Services<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
The Arazy Group expertise is regulatory affairs and quality assurance for the medical<br />
device industry.<br />
Arazy Group offers medical device registration services in more than 53 countries and have<br />
gained market clearance for medical devices and IVDs in North and <strong>South</strong> America, most<br />
European countries, various Asian markets, MENA, Africa and Australia. We implement<br />
advance global regulatory products that enable our client to overcome the traditional;<br />
multiple-country regulatory compliance that is currently achieved through multiplesubmission<br />
processes.<br />
For more than 16 years, our professional consultants have utilized validation, verification<br />
and regulation processes on a diverse portfolio of medical devices, and are responsible for<br />
thousands of successful registrations globally. Our customized solutions accommodate all<br />
stages of medical device’s life cycle and our adaptable services fit any application and any<br />
size organization. We Expedite Success of Safe <strong>Medical</strong> Devices.<br />
<strong>Technology</strong> and Product(s)<br />
GlobaR – One World Process<br />
Traditionally, multiple-country regulatory compliance is achieved through multiplesubmission<br />
processes. The common practice is fragmented, inefficient, costly and time<br />
consuming.<br />
GlobaR regulatory intelligence system generates unique Global Master Regulatory File<br />
for any medical device called a GlobaR dossier. The following registration process is<br />
quick and efficient since this single file complies with international harmonized standards,<br />
local standards and manufacturing quality management system, creating one universal<br />
dossier which shows your device is safe and effective.<br />
Whether you are seeking enter your device into one market or multiple markets, we have<br />
the solution Our experts are often outsourced for quality and regulatory (QA/RA) positions<br />
to design and implement regulatory strategy for some of the most advanced and complex<br />
devices. Our past experiences comprise of successful registrations of various medical<br />
device categories such as, Drug Delivery, Imaging and Navigation systems, Diagnostic<br />
Software Energy emitting technology, Therapeutic Devices, Combination Devices, Active<br />
and Passive Implants, Diabetic Products, IVDs, Surgical Disposables, Dental Implants and<br />
Dental Lab Products.<br />
Goal<br />
Objectives: Increase client base and locating local agent in additional countries.<br />
Target Businesses: <strong>Medical</strong> device manufactureres, regulatory affairs consultants and<br />
R&D companies<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
18
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Beth-El Industries<br />
www.beind.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
E.M.S<br />
General Surgery<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Beth-El Industries is a leading developer and manufacturer of medical negative pressure<br />
isolation systems and collective NBC filtration systems.<br />
Drawing on more than 30 years of experience in the air filtration field, Beth El Industries<br />
Ltd. now offers the medical market an array of stationary and portable Isolation Chambers,<br />
Clean Rooms and stand-alone Air Filtration Systems for applications in hospitals and<br />
ground or airborne ambulances.<br />
Beth-El’s IsoArk® isolation chambers are designed to quarantine infected people and<br />
protect the outside enviroment from contagious diseases like SARS, Ebola and TB.<br />
A unique series of products was developed and are now used by International Disaster<br />
Relief organization in difficult environments worldwide.<br />
Our main features:<br />
• Quick and effective isolation • Simple and fast assembly with no additional tools • Portable<br />
solution can be brought to the problem • Variety of sizes and custom manufacturing<br />
according to our client’s requests • Costs only a fraction of the price of a permanent<br />
stationary isolation rooms.<br />
Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS<br />
9100 quality management systems and is audited regularly by external entities.<br />
<strong>Technology</strong> and Product(s)<br />
IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated<br />
environment, for a quick and effective isolation of contagious people and equipment.<br />
The system includes an airlock attached to the main chamber, an air filtration system and<br />
special features that enable to treat the patient from the outside, avoiding contamination<br />
of equipment and staff.<br />
All components of the system meet and exceed today’s standards for infection isolation.<br />
IsoArk N36-4 - portable isolation chamber for transport of a single person in biological isolation.<br />
Designed specifically for the unique requirements and confided spaces of ambulances<br />
and helicopters, this new product incorporates both Isolation Chamber and Clean Room<br />
features, cleaning both the incoming and the outgoing air. Either positive or negative air<br />
pressure can be created inside the chamber, according to the users needs.<br />
With the battery fully charged, the system can operate for up to 10 hours independently<br />
of external power source and guaranties a complete isolation of the space inside the<br />
chamber during transport.<br />
The “collapsible”, lightweight structure allows for a quick set up of the system and<br />
minimal storage requirements when not in use.<br />
Schedule a Meeting at<br />
Goal<br />
Objectives:<br />
• Agent able to promote our products in the medical and emergency prepardness sectors<br />
in his country<br />
• Contact with potential end customers.<br />
Target Businesses: Government agencies in charge of emergency prepardness, hospitals,<br />
importers and distributors of medical equipment, ministry of health, ambulance and<br />
ambulance equipment companies, airports.<br />
Target Countries: Worldwide<br />
Return to Table of Content<br />
19
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Biovo Technologies<br />
admin@biovo.net<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Disposables and<br />
Implantable<br />
Company Status:<br />
Pre-Clinical<br />
Company at a Glance<br />
Biovo develops breakthrough products for hospital intensive care (ICU). Our products aim<br />
to provide highly effective patient care, with less nurse work effort, and reduce VAP risk.<br />
<strong>Technology</strong> & Product(s)<br />
Breakthrough products for hospital intensive care (ICU):<br />
(1) AirVent - Effective ETT biofilm cleaning integrated in a closed suction system. Biofilm<br />
buildup clogs ETT tubes, increase risk of VAP and decrease air patency of the ETT lumen. The<br />
AirVent Closed Suction System incorporates new lumen cleaning capabilities combination<br />
with conventional suction action within the familiar closed suction framework.<br />
(2) PoliVent – VAP infection prevention with novel non-inflatable self-expanding cuff of<br />
Endo-tracheal tubes. All present ETT inflatable cuff balloon systems fail to effectively<br />
prevent leak of infected oral fluids considered the primary source of VAP infection in ICU.<br />
All present ETT cuff pressure is unstable require repeated adjustments by ICU nurse. For<br />
the first time, the Poliventreplace the balloon with a new fluids blocking cuff system. The<br />
PoliVent ETT cuff is self-expanding with no need of air inflation and no need of repeated<br />
pressure monitoring and adjustment by the ICU nurse, and providing continuous stable<br />
blocking of infected fluids leak.<br />
Goal<br />
Objectives: Identify relevant and interested distribution partners & manufacturing<br />
partners<br />
Target Businesses: <strong>Medical</strong> device distribution company with presence in Intensive Care<br />
Units<br />
Target Countries: Europe (primary); U.S. and Asia (secondary)<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
20
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
BSP Biological Signal Processing<br />
www.bspmedical.com<br />
Category:<br />
Diagnostics<br />
Cardiovascular and<br />
Peripheral Vascular<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
Founded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with<br />
corporate offices in Tel Aviv, <strong>Israel</strong> and a US subsidiary – BSP Inc. in Boston, MA. BSP is<br />
publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP).<br />
BSP develops and commercializes a new generation of systems for non invasive diagnosis<br />
and monitoring of Coronary Artery Disease (CAD), based on advanced signal processing of<br />
the ECG signal which integrates the Company’s unique, patented, HyperQ technology.<br />
<strong>Technology</strong> and Product(s)<br />
BSP has pioneered the clinical implementation of high-frequency ECG and has developed<br />
it into a fast, accurate, low-cost, simple to operate and non-radiating technology for<br />
detecting CAD with greater clinical value than the current standard ECG. The company’s<br />
proprietary HyperQ technology extracts and analyses the high-frequency components<br />
of the ECG and provides a unique diagnostic index. Thousands of patients have been<br />
tested with the HyperQ system to date, demonstrating consistently that HyperQ is far<br />
superior to conventional ECG both in sensitivity and specificity, with the potential to<br />
save up to 50% of the unnecessary radioactive imaging procedures, while improving the<br />
standard of care. BSP’s Intellectual Property portfolio is backed by four granted patents<br />
and 14 filed applications in different stages.<br />
HyperQ EX-300: The world’s first advanced system incorporating conventional stress ECG<br />
and the revolutionary highly accurate HyperQ CAD diagnosis in a single, small footprint<br />
unit. This system is FDA (510k) cleared and CE marked.<br />
HyperQ AD-100: Seamlessly integrating the highly accurate HyperQ CAD diagnosis into<br />
the existing workflow, HyperQ AD-100 is an “add-on” to standard stress ECG systems,<br />
enhancing conventional ECG results. This system is FDA (510k) cleared and CE marked.<br />
Goal<br />
Objectives: The Company’s primary strategic objectives include establishing HyperQ as<br />
the first line modality for monitoring and diagnosis of CAD in cardiology clinics, ambulatory<br />
and hospital settings and attaining reimbursement code and premium coverage over<br />
competitors for the HyperQ diagnostic modality in the US. Growth in market penetration<br />
and market share will be achieved through a combination of business partnerships<br />
with equipment and healthcare service providers, and by the establishment of a global<br />
marketing and sales presence.<br />
Target Businesses: Distributors specializing in cardiovascular diagnostic devices, leading<br />
manufacturers in the field of cardiovascular diagnostic devices for potential business<br />
partnerships, leading health service providers.<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
21
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Cnoga <strong>Medical</strong><br />
www.cnoga.com<br />
Category:<br />
Monitoring<br />
Cardiovascular and<br />
Peripheral Vascular<br />
Diagnostics<br />
General Health<br />
Aesthetics and<br />
Dermatology<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
Cnoga <strong>Medical</strong> is an innovative developer of easy-to-use, touch free and non-invasive<br />
medical devices.<br />
It is Cnoga’s belief that the time is soon approaching when most blood tests will be<br />
conducted by the patients themselves, in the comfort of their own homes, and with a<br />
simple non-invasive device.<br />
<strong>Technology</strong> and Product(s)<br />
CNOGA <strong>Medical</strong>’s technology provides a new patent pending and state of the art solution<br />
for the non-invasive / touch free methods of measuring physiological parameters.<br />
CNOGA’s technology is based on real-time tissue photography, tissue image color is being<br />
processed in real-time, providing the temporarily color distribution, using dynamic range<br />
of at least 36 color-depth representing over 6.8^10 color combination then by using<br />
sophisticated mathematical algorithm, the vast amount of information is being computed<br />
and analyzed for detecting the correlation between temporarily color pigmentation and a<br />
specific bio or physiological parameter.<br />
Products:<br />
The TensorTip VSM – Pulse rate, Blood Pressure and SpO2 monitoring device<br />
The Hemoximeter – Hemoglobin, Pulse rate, SpO2 monitoring device<br />
The Glucometer – Blood glucose, non-invasive, monitoring device<br />
Goal<br />
Objectives: Meet potential business partners and distributors as well as potential<br />
customers<br />
Target Businesses: <strong>Medical</strong> Device Distributors, hospitals and medical insurance<br />
companies<br />
Target Countries: Global<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
22
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
CoolSense <strong>Medical</strong><br />
www.coolsense.net<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Aesthetics and<br />
Dermatology<br />
General Health<br />
Neurology and<br />
Degenerative<br />
Diseases<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
COOLSENSE <strong>Medical</strong> Ltd. is a subsidiary of the M.D. Clinic Group based in Tel-Aviv, <strong>Israel</strong>;<br />
an established and prestigious medical health center whose specialty in non-surgical<br />
aesthetic procedures serve an extensive network of cosmetic treatment clinics.<br />
CoolSense <strong>Medical</strong> Ltd. was responsible for the R&D that preceded the manufacture of<br />
the innovative hand-held CoolSense pain numbing applicator. CoolSense’s successfully<br />
implemented concept offers medical personnel, aestheticians and the general public a<br />
revolutionary but simply operated instrument that eliminates the pain and discomfort of<br />
injection procedures. CoolSense Pain Numbing Applicator which received CE approval,<br />
FDA Certification as well as the <strong>Israel</strong>i “Certificate of Free Sale” is in use worldwide.<br />
CoolSense <strong>Medical</strong> intends launching MIGROCALM during Medica 2011. MIGROCALM<br />
is an innovative self-regulated therapeutic device for the emergency relief of severe<br />
migraine type head pain.<br />
<strong>Technology</strong> and Product(s)<br />
The innovative CoolSense device, when applied to the skin immediately anesthetizes the<br />
site of injection with no after effects. The CoolSense Pain-Free Injection Applicator has<br />
been accepted as an indispensable instrument for health care personnel when performing<br />
medical or cosmetic skin invasive procedures. The CoolSense Applicator is also an<br />
invaluable tool that greatly improves the quality of life for individuals who are obliged to<br />
undergo injection procedures on a daily basis.<br />
CoolSense acts within 3-5 seconds to do away with the stress and fear that is associated<br />
with receiving injections, the most common health-care procedure worldwide.<br />
The MIGROCALM - An innovative self-regulated therapeutic device for the emergency<br />
relief of severe migraine type head pain. MIGROCALM has been designed for personal<br />
use in the home; offers drug-free, noninvasive and highly effective relief of severe migraine<br />
associated head pain.<br />
Goal<br />
Objectives: Finding potential distributors for main European and Latin American countries<br />
Target Businesses: Distributors<br />
Target Countries: Germany, France, Switzerland, UK, Latin America.<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
23
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Discover <strong>Medical</strong> Devices<br />
www.discovermedical.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Respiratory and<br />
Pulmonary<br />
Company Status:<br />
Clinical Trials<br />
Company at a Glance<br />
Discover <strong>Medical</strong> Devices (DMD) has developed a revolutionary new Continuous Positive Air<br />
Pressure (CPAP) interface – the SomnuSeal masks line for Obstructive Sleep Apnea (OSA).<br />
Patients quickly adjust to the comfortable self-adaptable oral mask, solving the market’s<br />
greatest problem – how to increase the low compliance rates for CPAP treatments. This is<br />
an unmet need and DMD is the first to successfully address it. DMD makes it possible for<br />
the market, with its well established distribution, sales and reimbursement infrastructure,<br />
to grow from $3B and reach its full $30B potential.<br />
SomnuSeal benefit for a strategic partner:<br />
• Will increase worldwide market by >3b$/yr<br />
• Answers an unmet need (no current competition)<br />
• Perceived “Innovative” and “Leading edge” technology.<br />
• Will provide a massive competitive advantage and ‘locking in’ of the newly acquired<br />
market share of non compliant patients<br />
<strong>Technology</strong> and Product(s)<br />
Approximately 5% of the population requires CPAP treatment for OSA, including more<br />
than 15 million people in the US and 350 million more around the world.<br />
DMD designed the revolutionary SomnuSeal masks from the ground up to solve the most<br />
serious problem in the OSA market today – despite the dangers of OSA, roughly 50%<br />
of diagnosed patients stop their CPAP treatment because they cannot sleep comfortably<br />
with the cumbersome masks that exist today.<br />
In contrast to available traditional masks, DMD’s solution (the SomnuSeal masks line) uses<br />
the natural oral cavity anatomy to create the seal required for effective CPAP treatment.<br />
This innovative development makes it very easy for patients to quickly adjust to the DMD<br />
small self-adaptable mask, which does not occupy external facial structures, does not<br />
contact sensitive internal oral structures, and does not create any of the side effects that<br />
are typical of existing devices.<br />
The SomnuSeal is the first and only mask that addresses the non compliant patient market<br />
segment successfully.<br />
Goal<br />
Objectives: To establish distribution network<br />
Target Businesses: Distributors that are experienced and successful in sales to sleep<br />
apnea patients<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
24
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
DYN Diagnostics<br />
www.dyn.co.il<br />
Category:<br />
Diagnostics<br />
Robotics<br />
Laboratory<br />
Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Dyn Diagnostics Inc. is engaged in marketing, sales and support scientific and engineering<br />
field tests of body fluids IVD - (In Vitro Diagnostics) and in research laboratories (Applied<br />
Science).<br />
Dyn Diagnostics was founded in 1990 and since its inception some twenty years ago, is<br />
the exclusive representative in <strong>Israel</strong> of Roche Diagnostics, which is the world’s largest and<br />
leading company in the IVD field.<br />
The company completes it’s product line in which Roche is inactive by representing leading<br />
companies such as - (Horiba ABX, Grifols, Aesku.Diagnostics etc.), wide product range<br />
allows the perfect offering and comprehensive solutions in the field of diagnostics.<br />
Dyn Diagnostics is working to implement technologies, innovative processes and advanced<br />
testing of human body fluids in the various performance sites. The company’s activity is<br />
based on a foundation of over a hundred employees with a broad education and skills such<br />
as - biological sciences and engineering, information systems, distribution and logistics as<br />
well as on experience and knowledge accumulated in the last twenty years.<br />
<strong>Technology</strong> and Product(s)<br />
DYN DS Decapper, Sorter and Archiver<br />
The DYN DS is a primary sample decapper/sorter and archiver that is built to efficiencies.<br />
The DYN DS decaps different types of closures on standard primary sample tube sizes<br />
and automatically sorts up to 1,000 tubes per hour. Tubes are sorted for any laboratory<br />
analyzer or target and then finally for archiving.<br />
Genotype DNA marker kits<br />
We at Dyn market commercial vegetable DNA marker tests.<br />
We have been marketing DNA marker test kits, and services locally, for more than 3 years,<br />
to all major local vegetable breeders\seed companies.<br />
Our customers use our test either as a DNA marker selection tool to assist breeders, or as<br />
a post control tool to confirm seed production purity.<br />
Goal<br />
Objectives:<br />
• Establish Joint Ventures;<br />
• Find Business Partner that would like to represent our products in various countries;<br />
• Establish business reletaions with international <strong>Medical</strong> Device companies looking to<br />
enter the <strong>Israel</strong>i market.<br />
Target Businesses: Distributors<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
25
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
EarlySense<br />
www.earlysense.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Monitoring<br />
General Health<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
EarlySense is bringing to the market an innovative contact-free patient supervision<br />
technology.<br />
EarlySense’s continuous early sensing capabilities and patient management tools empower<br />
the medical staff in the unmonitored units to improve clinical outcomes and reduce<br />
pressure ulcers and patient falls by measuring key parameters through a sensor places<br />
underneath the patient’s mattress.<br />
The continuous patient supervision device that follows and documents patients’ vital signs<br />
and movement, allows nursing staff to proactively reduce adverse events.<br />
EarlySense’s system bridges the critical time gap between patient deterioration and<br />
clinician intervention. In light of the Joint Commission’s 2009 Patient Safety Goals for<br />
healthcare organizations, EarlySense’s technology offers a timely solution for detecting<br />
changes in a patient’s condition, while also assisting nurses to focus on the patients who<br />
need their immediate attention.<br />
<strong>Technology</strong> and Product(s)<br />
EarlySense’s technology has three main components:<br />
1. A unique single plate sensing unit<br />
2. A bedside monitor that processes and displays the measured data; and -<br />
3. A Central Display Station that enables complete coverage of a unit wide set of monitors<br />
at the nurses’ station and the different alerts are delivered to the nurses’ handheld<br />
devices.<br />
The system’s built-in management tools include a wide range of reports on the status of<br />
patients at all times and can be printed for documentation and clinician analysis. Once<br />
placed under a bed mattress, the sensing unit immediately self-activates when sensing<br />
the patient in bed. The system is FDA cleared and CE approved and has been shown to<br />
improve clinical outcomes in general care units.<br />
Goal<br />
Objectives: To be a market leader in the <strong>Medical</strong> Supervision Field<br />
Target Businesses: Sales in USA, Major Clinical study in Harvard/leading university<br />
Target Countries: US, Europe<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
26
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Elitar <strong>Medical</strong><br />
www.elitr.com<br />
Category:<br />
Diagnostics<br />
Monitoring<br />
Telemedicine and<br />
Healthcare IT<br />
Cardiovascular and<br />
Peripheral Vascular<br />
General Health<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
Elitar <strong>Medical</strong> is a medical device company founded in <strong>Israel</strong> in 2005. The company’s<br />
mission is to offer a full range of non-invasive, multi-parameter patient monitoring devices<br />
and health management software tools to the full satisfaction of its customers and endusers.<br />
Elitar stations can be used for preventive screening for emergency room of national<br />
hospitals. Elitar develops and manufactures distinct and innovative products hardware<br />
and software.<br />
The company’s unique approach encourages the adoption of a preventative medicine<br />
and healthy lifestyle by simplifying the diagnosis and implementation processes by health<br />
stations, both of the individual and for the accompanying professionals.<br />
<strong>Technology</strong> and Product(s)<br />
Elitar provides: health station, specially designed to meet the needs of individuals and<br />
organizations that either wish to cut down their costs (e.g., hospitals and retirement<br />
homes), to increase their profits (e.g., pharmacy chains and gyms), or to improve their<br />
health and nutrition management.<br />
The health station provide gold standard measurement some or all of the following vital<br />
signs: height, weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate),hand grip<br />
strength test, body composition, blood pressure, pulse rate, electrical activity of the heart<br />
(EKG), heart rhythm regularity oxygen saturation, body temperature – all through a quick,<br />
non-invasive, single-posture process. In addition, they can be complemented by external<br />
monitoring devices.<br />
Elitar’s health station is automatically subscribed to the complementary health and weight<br />
management software BioFat and can be subscribed to Telehealth CheckUp, Elitar’s most<br />
advanced health station model, also includes video-conferencing any other external<br />
database, including electronic medical records (EMRs) and other telecommunications<br />
features, and can be also compatible with the medical magnetic or smart card.<br />
Goal<br />
Objectives: To establish distribution network worldwide, joint-ventures with customers<br />
or distributors of diagnostic devices, health insurance companies<br />
Target Businesses: Hospitals, private clinics, medical devices distributors, health spa<br />
channels, pharmacies<br />
Target Countries: Europe, Asia, North Africa, Middle East<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
27
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Erika Carmel Ltd.<br />
www.gd-energies.com<br />
Category:<br />
Wound and Pain<br />
Management<br />
Aesthetics and<br />
Dermatology<br />
Rehabilitation<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
As a company whose goal is to bring innovations in treatment, care, and quality of life to<br />
more and more people, we are proud to present you with cutting edge technology in soft<br />
Laser Therapy: B-Cure Laser is the world’s first portable soft Laser medical device WITH<br />
THE HEALING POWER OF A CLINIC.<br />
B-CURE Laser is recommended by the best leading specialists and is used widely in <strong>Israel</strong><br />
by the leading pain clinics, wound healing clinics, and orthopedic departments in the<br />
following hospitals: Hadassah-Jerusalem, Sourasky, Rambam, and Shiba (Tel Hashomer).<br />
It is also used in physiotherapy clinics of <strong>Israel</strong>i Defense Forces, leading sports clubs, and<br />
the best sportsmen in <strong>Israel</strong>, as well as by thousands of individuals for self-treatment at<br />
home.<br />
On January 2010 B-Cure Laser received the European CE 0120 approval for 16 indications<br />
and is presently being exported to some European countries. CE 0120 approved indications<br />
for the B-Cure Laser are: knee pain, neck pain, pain in lower and upper back, sports<br />
injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, achilles tendonitis, carpal tunnel<br />
syndrome, inflammation, wound healing, burns, fresh surgical scars, post-pregnancy<br />
stretch marks, acne, herpes simplex, dental medicine, acupuncture.<br />
<strong>Technology</strong> and Product(s)<br />
B-Cure Laser - LLLT 808 - Low Level Laser Treatment<br />
The soft-laser affects the skin’s surface and simultaneously penetrates the skin without<br />
heating or hurting the skin. Soft laser treatment biostimulates the body’s natural healing<br />
mechanism on a cellular and systemic level. The result: every kind of cell receives the<br />
energy required for activating and enabling optimal functioning in the body, thus allowing<br />
it to “self-heal” and naturally overcome specific problems.<br />
B-CURE LASER - an international breakthrough in soft-laser therapy for professional and<br />
personal treatment of the above mentioned indications.<br />
Thanks to an exclusive, patent-pending development, we have created an exceptional<br />
combination: the power and full coherence of a clinic’s soft-laser device over a large<br />
area of 4.5 cm², with a portable, rechargeable, safe and easy-to-use device – all at a<br />
reasonable price.<br />
The result: a perfect combination of the most effective therapy with the ability to provide<br />
immediate and continuous treatments, thus enabling high quality and fast recovery in<br />
shorter individual treatment times, and with less total healing time.<br />
OUR INNOVATION FOR MEDICA 2011: B-CURE LASER PROFESSIONAL.<br />
Schedule a Meeting at<br />
Goal<br />
Objectives: Distribution<br />
Target Businesses: End-users for self-treatments at home, Pharmacies-a unique business<br />
model, Clinics, Hospitals, Sports teams, Athletes, Security forces, Home care, Nursing<br />
homes.<br />
Target Countries: EU, USA, <strong>South</strong> America, Australia<br />
Return to Table of Content<br />
28
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Estar <strong>Medical</strong><br />
www.estar-medical.com<br />
Category:<br />
<strong>Medical</strong> and Hospital<br />
Equipment<br />
Company Status:<br />
Revenue Growth<br />
Schedule a Meeting at<br />
Company at a Glance<br />
Estar <strong>Medical</strong> develops, produces and markets a wide range of superior medical products<br />
for healthcare professionals and laboratories.<br />
Estar’s main areas of activity are:<br />
• Assisted Reproduction Technologies (A.R.T) – <strong>Israel</strong>’s No. 1 expert and distributor of A.R.T<br />
products, being a one-stop-shop for establishing fertility labs and providing innovative<br />
turn-key solutions in <strong>Israel</strong> and abroad. Estar continuously upgrades and enhances its<br />
product portfolio with state-of-the-art products from the leading companies, such as<br />
in the pioneering fields of In Vitro Maturation (IVM) and Vitrification.<br />
• Regenerative Medicine – in-house development of TropoCells Platelet Preparation<br />
System for the separation of platelet concentrates from the patient’s own blood. The<br />
TropoCells product line provides creative solutions for a wide range of applications<br />
and users. Estar’s goal is to develop unique products isolated from autologous peripheral<br />
blood, based on its core competencies in blood collection and separation.<br />
• Vacuum-based blood & urine collection - Estar <strong>Medical</strong> was among the world pioneers<br />
in this field.<br />
<strong>Technology</strong> & Product(s)<br />
The TropoCells Platelet Preparation System – based on Estar’s proprietary technology - is<br />
designed to concentrate platelets with their associated growth factors from the patient’s<br />
own blood.<br />
Estar <strong>Medical</strong> provides a wide range of solutions for Sports Medicine, Plastic Surgery,<br />
Chronic Wounds, Dentistry and Veterinary Medicine.<br />
The TropoCells platform technology enables easy adjustments to an ever growing<br />
range of medical applications, as well as offering tailor-made solutions for specific<br />
requirements.<br />
The unique design of TropoCells enables:<br />
• High yield of platelets with available growth factors<br />
• Time-saving - only one centrifugation is required<br />
• Easy handling and processing<br />
• Efficient collection of the platelet concentrate utilizing the TropoCells proprietary<br />
Filtering Sleeve<br />
• Filtering WBC types out of the platelet concentrate using the TropoCells Filtering<br />
Sleeve (optional)<br />
• Preparation in doctor’s office<br />
• Maximum modularity & flexibility - easy adjustment to different varieties of applications<br />
and users<br />
Products are CE marked, FDA cleared and manufactured in compliance with Quality<br />
Standards EN ISO 13485:2003 and ISO 9001:2008<br />
Goal<br />
Objectives: Seeking partners/distributors for the TropoCells Platelet Preparation System<br />
product line<br />
Target Countries: World-wide<br />
Return to Table of Content<br />
29
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
ETView<br />
www.etview.com<br />
Category:<br />
Disposables and<br />
Implantable<br />
Intensive Care<br />
General Surgery<br />
Respiratory and<br />
Pulmonary<br />
E.M.S<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
ETView is a commercial stage, publicly traded medical device company focused on<br />
combining airway management with continuous direct visualization for multiple<br />
thoracic surgical procedures as well as long term ventilator dependent patients. ETView<br />
manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with<br />
a camera and a light source. TVT combines high-flow ventilation, airway management<br />
and continuous video monitoring to overcome current limitations and associated adverse<br />
surgical procedure events during lung isolation surgeries as well as managing and limiting<br />
potential surgical injuries resulting from percutaneous tracheotomy and anticipated<br />
difficult intubations.<br />
The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing<br />
intubation skills to medical students, anesthesiology residents and emergency personnel.<br />
<strong>Technology</strong> and Product(s)<br />
ETView’s patented single-use tracheoscopic ventilation tube (TVT) incorporates a video<br />
camera and light sourc embedded in the tip of an endotracheal tube. The images from<br />
the TVT can be viewed on ETView’s dedicated monitors, or on other hospital medical<br />
monitors.<br />
With a camera at this critical location, medical personnel can effectively monitor surgical<br />
procedures such as the placement of endo-bronchial blockers in lung isolation procedures<br />
and the performance of percutaneous tracheotomy in long term ventilated patients in<br />
the ICU as well as constantly monitor the endotracheal tube tip’s position in such patient<br />
groups.<br />
The TVT is indicated for use in the OR and ICU.<br />
Goal<br />
Objectives: To find distributors which will sell the TVT in their respective markets<br />
Target Businesses: Distributors<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
30
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
First Care Products<br />
www.firstcareproducts.com<br />
Category:<br />
Disposables and<br />
Implantable<br />
E.M.S<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
First Care Products specializes in the development and marketing of new products for prehospital<br />
emergency medical situations. The company’s mission is to provide intelligent,<br />
innovative, effective and simple to use products which assist in life-saving, improve the<br />
treatment provided and yield significant savings in time and resources.<br />
Save One Life, Save A World<br />
Active in medical R&D, the company develops beneficial solutions for pre-hospital<br />
medical emergencies. First Care Products provides medics, first responders and the<br />
injured themselves with easy and quick to use, effective products for the control of<br />
hemmorhage resulting from trauma that save lives and greatly boost the treatment<br />
provided whether on the battlefield, homefront or accident scene. The company brings<br />
its years of comprehensive R&D and field experience to create products that when every<br />
second counts make the difference between life and tragedy.<br />
<strong>Technology</strong> and Product(s)<br />
The Emergency Bandage<br />
First Care Products’ first and flagship product, The Emergency Bandage in all its versions<br />
has been designated as the “STANDARD” Personal Field Dressing by numerous major,<br />
quality military organizations and is being utilized by Special Forces and military medical<br />
corps worldwide. The Emergency Bandage is combat and clinically proven, being relied<br />
upon as an integral and vital component in the treatment of hemorrhage and trauma<br />
related injuries.<br />
Beyond Military Use<br />
In addition to militaries around the world, First Care Products supplies its innovative<br />
bandages to governmental and private emergency medical services, Fire Rescue, Police and<br />
Prison Authorities, First-Aid and Survival Academies, and suppliers of first-aid equipment<br />
to the general public.<br />
Worldwide Patent and Approvals<br />
First Care Products’ bandages are Patented worldwide, FDA and CE Approved, with Health<br />
Ministry Approvals in each territory, NATO Reference Numbers, and NSN’s in the USA.<br />
First Care Products manufactures all its products according to the highest International<br />
Standards including ISO 13485.<br />
Goal<br />
Objectives: Strategic Alliances<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
31
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Flight <strong>Medical</strong> <strong>Innovation</strong>s<br />
www.flight-medical.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Rehabilitation<br />
Intensive Care<br />
Respiratory and<br />
Pulmonary<br />
E.M.S<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Flight <strong>Medical</strong> is a leading manufacturer of high end PORTABLE VENTILATORS. The company<br />
developed and manufacture the legendary HT50 and sold over 15,000 worldwide. Flight<br />
<strong>Medical</strong> has recently launched the Flight 60 ventilator deploying its proprietary leading<br />
edge technology.<br />
<strong>Technology</strong> and Product(s)<br />
The Flight 60 follows the success of more than 15,000 HT50 ventilators deployed<br />
worldwide. Flight 60 is an all-purpose ventilator designed to address the growing need<br />
for ventilation in Home Care, Long Term Care, Emergency, Transport, Hospital and Sub-<br />
Acute. The newly introduced Flight 60 Ventilator is offering a lot more –<br />
• A Complete Ventilation Suite<br />
• All Pressure and Volume ventilation modes<br />
• Actual flow measurements (Vti,Vte)<br />
• Embedded FiO2 sensor<br />
• Single limb and dual limb mode<br />
• Autonomous<br />
• 12 hours battery life further extended by hot swap<br />
• Low flow and high pressure oxygen source connection<br />
• Light weight, portable and robust<br />
• Intuitive and Easy to Use<br />
• 7” colored touch screen<br />
• All ventilation parameters on a single screen<br />
• Enhanced graphical display<br />
• Cutting-Edge Dual Micro Piston <strong>Technology</strong><br />
• Top clinical performance<br />
• Low power and O2 consumption<br />
• Low heat generation<br />
• Low cost of ownership<br />
Goal<br />
Objectives: Establish global distribution network.<br />
Target Businesses: Distributors of medical devices to Home Care, Hospitals and Long<br />
Term Care markets<br />
Target Countries: Asia, Americas, Europe, India<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
32
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
FlowSense Ltd.<br />
www.flowsensemedical.com<br />
Category:<br />
<strong>Medical</strong> and hospital<br />
Equipment<br />
Monitoring<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
FlowSense’s product, URINFO 2000, enables physicians to optimize fluid management and<br />
acute renal care by automating the monitoring of urine output accurately, continuously,<br />
and in real-time.<br />
<strong>Technology</strong> & Product(s)<br />
URINFO 2000 offers automated urine output monitoring for patients in the acute care<br />
setting. Today, there is no effective means by which this important marker can be measured<br />
and captured reliably, continuously, and in real-time. Urine output, today, is measured<br />
with mechanical urine meters which are labor intensive, based on manual volume<br />
readings, and do not provide current urine output data. URINFO 2000, enables physicians<br />
to optimize fluid management and acute renal care by automating the monitoring of<br />
urine output accurately in real-time, continuously. Automated monitoring can result in<br />
earlier detection, more rapid intervention, and improved patient outcomes and reduced<br />
hospital costs. URINFO 2000 is comprised of a small electronic unit (display and cradle<br />
for disposable) installed on the bed and a disposable that connects to any catheter and is<br />
proprietary to the URINFO system. The product is in daily use in several hospitals.<br />
Goal<br />
Objectives: Identify relevant and interested distribution partners<br />
Target Businesses: <strong>Medical</strong> device distribution companies with presence in Intensive<br />
Care Unit and Operating Room<br />
Target Countries: Europe (primary); U.S. and Asia (secondary)<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
33
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Gilco pharm<br />
www.gilcopharm.com<br />
Category:<br />
Pharmaceuticals<br />
Aesthetics and<br />
Dermatology<br />
E.M.S<br />
Wound and Pain<br />
Management<br />
Company Status:<br />
Regulatory<br />
Approval<br />
Company at a Glance<br />
Gilco Pharm is a well established pharmaceutical company that manufactures and markets<br />
high quality, innovative, <strong>Medical</strong> Devices, Medico-Cosmetics and Food Supplements.<br />
Our main focus is treatment and prevention in the following fields: Dermatology,<br />
Gastroenterology and ENT.<br />
From its inception as a family business in 1994, by Pharmacist Mr. Gil Tagger Gilco Pharm<br />
has made it it’s goal is to provide patients with the best possible therapies for a diverse<br />
range of needs and help improve their quality of life.<br />
Our highly skilled professional team is dedicated to excellence and is committed to staying<br />
constantly at the forefront of scientific development as well as keeping a competitive edge,<br />
by being highly flexible in today’s changing market. Gilco Pharm combines professional<br />
and logistical skills in the medical field with good connections in the marketplace.<br />
Gilco Pharm implements four ISO systems, including: ISO 9001:2008, ISO 13485:2003,<br />
ISO 22716:2007 and ISO 22000:2005.<br />
<strong>Technology</strong> & Product(s)<br />
GILCO PHARM focuses on the development and production of products for the following<br />
conditions:<br />
Dermatology And Wound Care: A wide range of products for the prevention and<br />
management of dry skin conditions, atopic dermatitis, acne, wounds and burns.<br />
ENT preparations, based on Dead Sea salt, for the management of dry mouth and nose,<br />
sore throat and cough.<br />
Gastrointestinal – Phosphate free ready for enema, fibers syrup and Hemorrhoid gel.<br />
Lice Treatment – A unique pesticides free preparation and repellent.<br />
Personal Lubricants – including water base, silicone and warming lotion. Within this<br />
line, we also include a long lasting moisturizer and acidifying gel.<br />
Goal<br />
Objectives: Seeking distributors for our products<br />
Target Businesses: Distribute our brands or out-lisencing<br />
Target Countries: Europoe, USA and Asia<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
34
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Hyginex<br />
www.hyginex.com<br />
Category:<br />
Monitoring<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Hyginex, founded in 2008, brings a new era to hospital hygiene and infection control.<br />
Hyginex’s technology combines an advanced network of sensors, and an online server to<br />
process and display hand hygiene information.<br />
The Hyginex breakthrough enables for the first time real monitoring, management and<br />
control of the hospital staff hand hygiene protocol compliance and quality.<br />
With “You Can Control Only What You Can Measure” as its motto Hyginex’s product<br />
enables hospital management to receive simple and detailed reports that describe the<br />
hand hygiene compliance and the washing act.<br />
<strong>Technology</strong> and Product(s)<br />
The Hyginex system is a complete wireless hand hygiene monitoring system for healthcare<br />
staff – monitoring whether they clean their hands when needed and if they do so according<br />
to the protocol.<br />
The system creates detailed reports from the collected data and provides a simple and<br />
flexible user interface for understanding current status and trends of the hand hygiene in<br />
the hospital.<br />
Constant monitoring increases hand-hygiene compliance with almost no management<br />
effort and minimal educational overhead.<br />
On-line Real-time alert system enables management to be updated immediately on any<br />
deviation from the hospital defined hand hygiene policy.<br />
Personal alerting enables workers to receive immediate feedback that enables them to<br />
greatly improve their hand hygiene compliance and quality.<br />
Goal<br />
Objectives: System Marketing, Establishment of Distribution partnerships<br />
Target Businesses: Distributors<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
35
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
HypnoCore<br />
www.hypnocore.com<br />
Category:<br />
Diagnostics<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Monitoring<br />
Telemedicine and<br />
Healthcare IT<br />
Cardiovascular and<br />
Peripheral Vascular<br />
Respiratory and<br />
Pulmonary<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
HypnoCore’s vision is to become the global leader of sleep diagnostics services, devices,<br />
and solutions for the medical and consumer markets.<br />
HypnoCore Ltd. aims to revolutionize the field of sleep diagnostics and improvement<br />
solutions utilizing web and mobile technologies, medical and consumer devices, to allow<br />
accurate and affordable access to sleep diagnostics and health improvement solutions for<br />
the consumer and medical markets.<br />
<strong>Technology</strong> and Product(s)<br />
Following over a decade of academic research and years of R&D, HypnoCore Ltd. has<br />
developed patented, FDA and CE approved technology that analyzes the strongest and<br />
most robust signal, the electrocardiogram (ECG), in order to evaluate sleep and diagnose<br />
sleep disorders.<br />
Based on it’s core IP, HypnoCore developed a set of products:<br />
• HC1000P: HypnoCore’s flagship product - reliable, automated diagnostic software that<br />
relies on ECG and oximetry measurements to evaluate sleep and diagnose sleep related<br />
breathing disorders<br />
• HC1000: Diagnostic software that analyzes ECG data to diagnose insomnia<br />
• SleepWay: Web-based system for centralized scoring and data management<br />
• SleepRate: Utilizing the latest sensor technology, internet and mobile technologies,<br />
HypnoCore Ltd. is developing a new lineup of consumer products and services under<br />
the SleepRate brand<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
36
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
IceCure <strong>Medical</strong> Ltd.<br />
www.icecure-medical.com<br />
Category:<br />
<strong>Medical</strong> and Hospital<br />
Equipment<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
IceCure <strong>Medical</strong> Ltd. (TASE: ICCM) develops and commercializes office-based, minimallyinvasive,<br />
Cryoablation platform in the area of Women’s Health. One in 4 women in the<br />
U.S. is diagnosed with benign tumors in the breast (Fibroadenomas) or the uterus (uterine<br />
fibroids). These tumors account for > 700,000 surgeries each year in the U.S. IceCure<br />
offers a safe and effective treatment alternative to surgery, that may be performed in the<br />
physician’s office or in an outpatient facility.<br />
IceCure <strong>Medical</strong> Introduces IceSense3: a minimally invasive, office-based, Cryoablation<br />
treatment of breast Fibroadenoma. Clinical studies have shown Cryoablation to be a safe<br />
and effective alternative to surgery for treatment of breast Fibroadenoma. Based on these<br />
studies, a reimbursement code has been defined for in-office procedures (CPT 19105),<br />
and the American Society of Breast Surgeons (ASBS) has issued a consensus statement<br />
about the product’s safety, efficacy and durability.<br />
IceSense3 is approved for sale in the US and Europe.<br />
<strong>Technology</strong> & Product(s)<br />
IceSense3 unique technology uses liquid nitrogen for rapid freezing of the lesion. The<br />
system, with its intuitive graphical user interface is designed for maximum flexibility and<br />
simplicity for a single operator. IceSense3 is compatible with the latest advancements<br />
in ultrasound-guided interventions, such as 3D navigation, for a faster and more accurate<br />
procedure.<br />
IceSense3 is the natural choice for patients and physicians:<br />
• Excellent cosmetic results - Regardless of fibroadenoma size, the probe is inserted<br />
through a 3 mm incision, causing virtually no scar. No tissue is physically removed,<br />
hence there is no deformation of the breast, and there is no impact on the shape or<br />
appearance of the breast.<br />
• Quick Procedure - With the IceSense3 rapid cooling technology, treatment takes as<br />
little as 5-15 minutes (depending on the size of the treated area), saving precious time.<br />
• No pain - The freezing has an analgesic effect, so the patient hardly feels anything<br />
during treatment. Local anesthesia is used for the insertion of the probe, much like a<br />
biopsy procedure.<br />
• No Downtime - The patient can return to normal activities immediately after the procedure.<br />
With IceSense3, the treatment of breast FibroadenoUp-to 1250 Charachters<br />
Goal<br />
Objectives: Establish relationship with potential customers and distributors in Europe for<br />
Marketing and sales of the IceSense3.<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
37
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Intromedix<br />
www.intromedix.com<br />
:Category<br />
Disposables and<br />
Implantable<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
General Surgery<br />
Company status:<br />
Revenue growth<br />
Company at a glance<br />
Intromedix is an <strong>Israel</strong>i manufacturer of premium quality, cost- effective, generic, disposable<br />
surgical equipment.<br />
Intromedix has been certified ISO 13485 and has applied a Quality Management System<br />
according to 93/42/EEC. Certification was given by the German Notified Body Medcert.<br />
<strong>Technology</strong> andProduct(s)*<br />
• Surgical sutures - absorbable and non absorbable<br />
• Surgical staplers<br />
• Skin staplers<br />
• Surgical Mesh<br />
*All products are certified<br />
Goal<br />
Objectives: Establish global partnership channels for the distribution of our products<br />
Target Businesses: Distributors<br />
Target countries: All<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
38
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Itamar <strong>Medical</strong><br />
www.itamar-medical.com<br />
Category:<br />
Diagnostics<br />
Cardiovascular and<br />
Peripheral Vascular<br />
General Health<br />
Neurology and<br />
Degenerative<br />
Diseases<br />
Respiratory and<br />
Pulmonary<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Itamar <strong>Medical</strong> Ltd., is a public traded (TASE: ITMR) bio-medical technology company. Itamar<br />
develops and markets noninvasive diagnostic medical equipment based on proprietary<br />
PAT (Peripheral Arterial Tone) Signal. The PAT Signal serves as a noninvasive window<br />
to the Cardiovascular and Autonomic Nervous Systems.<br />
The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip<br />
by specialized noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based<br />
products are:<br />
• Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial<br />
function assessment – the precursor (earliest clinically detectable stage) of cardiovascular<br />
disease.<br />
• Watch-PAT200: ambulatory diagnosis of sleep related breathing disorders and sleep<br />
staging (Wake/REM/Deep sleep/light sleep stages).<br />
Both devices are used in preeminent clinical institutions, research centers and Pharmaceutical<br />
clinical phase studies in over 40 countries which have yielded nearly 300 publications.<br />
<strong>Technology</strong> and Product(s)<br />
Sleep testing - at home<br />
Considered “best in class”, WatchPAT (FDA cleared and CE marked) is a wrist mounted<br />
device for at-home testing of sleep apneas and sleep staging (REM/Deep Sleep/Light<br />
Sleep/Wake stages). WatchPAT also measures snoring and body position and provides a<br />
perfect combination of natural sleep at home with sleep-lab level data.<br />
WatchPAT works without the multiple cables and electrodes needed by other technologies<br />
which provide in-depth analysis of sleep, so it has an incredibly low failure rate. Yet the<br />
physician gets a comprehensive report with all the clinical parameters needed for patient<br />
treatment and monitoring. While the data is calculated automatically by the WatchPAT’s<br />
software, the physician can easily edit the data too.<br />
Noninvasive cardiovascular risk assessment<br />
Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field<br />
of endothelial function assessment, EndoPAT (FDA cleared and CE marked) is used in<br />
pre-eminent clinical institutions, research centers and Pharma studies. The noninvasive<br />
EndoPAT has been validated by nearly 100 publications and abstracts and provides<br />
clinicians with reliable and reproducible results in an office-based, 15 minute test.<br />
Goal<br />
Objectives: Establish wide distribution network in Europe<br />
Target Businesses: Distribution<br />
Target Countries: Brazil, Germany, UK, Spain, France, China, other<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
39
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Kapel - Kal<br />
www.kapelkal.com<br />
Category:<br />
<strong>Medical</strong> and Hospital<br />
Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Kapel-Kal Ltd. is a well-established, leading <strong>Israel</strong>i manufacturer and global exporter of<br />
high quality medical and treatment examination equipment. Kapel-Kal’s over 20 years of<br />
expertize and success is highly attributed to its corporate strategy of providing excellent<br />
products that are useful, flexible and convenient to install and use.<br />
Kapel-Kal offers two categories of products: General (“Off-the-Shelf”) Products and Tailor-<br />
Made Products. The General Product Category includes a vast variety of beds, treatment<br />
tables and chairs. The Tailor-Made Product Category enables Kapel-Kal Ltd. to provide<br />
superb products that are designed and built to meet very specialized requirements.<br />
<strong>Technology</strong> & Product(s)<br />
After 20 years of in-depth encounter with the healthcare and treatment industries,<br />
through manufacturing, marketing and service, Kapel-Kal had completed its flagship<br />
product: the Vision line. This well thought out, revolutionary, modular treatment-table<br />
is a base product which was carefully designed to serve its owner for a few decades.<br />
The product is practical and cost effective by being able to grow with each customer as<br />
that customer’s needs expand and change over the years. Varied modules are available<br />
to broaden the capabilities of the product and expand the type of work that can be<br />
performed with it.<br />
This one-of-a-kind product effectively serves caregivers of all fields, such as: Physiotherapy,<br />
Gynecology, Urology, Dermatology, and Veterinary. It can be used in clinics, laboratories,<br />
homes, spas and medical centers for examinations, operations, and treatments. Beyond the<br />
product’s features flexibility, it is also easy to transport, to assemble, and most importantly,<br />
to install the add-on modules and accessories, such as adjustable head rests (pneumatic<br />
or electrical), addition of side rails, wheels, retractable castors and much more.<br />
Goal<br />
Objectives: To export our products to distributers, medical centers and colaboration.<br />
Target Businesses: Cooperations, distributers, medical centers, clinic chains,<br />
manufacturer, universities.<br />
Target Countries: United States, Western Europe, Japan, Ukraine, Kazakhstan, Tailand, India.<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
40
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Medigus Ltd.<br />
www.medigus.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Initial Revenues<br />
Schedule a Meeting at<br />
Company at a Glance<br />
Medigus is a medical device company specializes in developing innovative endoscopic<br />
procedures and devices.<br />
Medigus is a pioneer developer of the SRS - a unique proprietary endoscopic device<br />
for the treatment of GERD, one of the most common chronic diseases in the western<br />
world. In addition, Medigus developed a line of miniatuearlysere video cameras, including<br />
models that are the smallest in the world.<br />
Based on its proprietary technologies, Medigus designs and manufactures endoscopy<br />
systems, for partner companies, including major players in the medical device industry as<br />
well as promising start-ups. Medigus advanced technology platform includes all necessary<br />
elements for performing a wide range of endoscopic procedures. The platform includes<br />
various types of rigid, semi-flexible and flexible video endoscopes, as well as respective<br />
endoscopy suites.<br />
From Concept-to-Product, we leverage our existing technological building blocks and<br />
combine the exceptional capabilities of our top medical and engineering experts to<br />
develop full-fledged medical devices at the highest standards, with exceptional efficiency<br />
and at the lowest prices.<br />
Medigus was established in 2000 and is a public company traded in the Tel-Aviv stock<br />
exchange since 2006.<br />
<strong>Technology</strong> & Product(s)<br />
1. Medigus developed an entire endoscopic system for intraluminal treatment of Reflux<br />
Disease (GERD). The innovative system performs an anterior fundoplication in lieu of<br />
the current surgical procedure without opening the abdominal cavity. The SRS combines<br />
a surgical stapler, ultrasonic sights for accurate positioning and a miniaturized video<br />
camera – all are Medigus proprietary technologies. The system contains all the requisite<br />
tools to complete the entire procedure and is controlled by a single physician.<br />
The system has a CE mark and successfully completed an international large-scale<br />
multi-center clinical trial.<br />
2. Medigus offers the world’s smallest video cameras. We offer a high performance, low<br />
cost, revolutionary CMOS camera, with an outer diameter of only 1.2mm – the smallest<br />
video camera in the world. The camera offers superb sensitivity, resolution and dynamic<br />
sensitivity. In small quantities Medigus provides a multi-use version of the camera, while<br />
in large quantities a single-use version is provided. The disposable camera eliminates<br />
the need for the costly sterilization. The camera is designed for endoscopes and in<br />
diagnostic and surgical medical procedures.<br />
We also offer multi-use 3.0x3.0mm and 1.8x1.8mm CCD cameras.<br />
Goal<br />
Objectives: 1. We seek distributors for the SRS endoscopic treatment of GERD. 2. We<br />
seek partners interested in developing mini-video-endoscopes based on our proprietary<br />
smallest video camera in the world for various medical applications.<br />
Target Businesses: 1. Distributors with proven experience in the endoscopic surgery field<br />
(i.e., bariatric, minimal-invasive, NOTES) and innovative medical devices. 2. Companies<br />
developing mini-endoscopes for medical applications.<br />
Return to Table of Content<br />
41
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Medoc<br />
www.medoc-web.com<br />
Category:<br />
Diagnostics<br />
Neurology and<br />
Degenerative<br />
Diseases<br />
Wound and Pain<br />
Management<br />
Company Status<br />
Revenue Growth<br />
Company at a Glance<br />
Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced<br />
thermal stimulators for the assessment of chronic pain. Medoc's products evaluate the<br />
small and large peripheral sensory nerve fibers (A-delta and C fibers), constituting the<br />
"Pain Pathway".<br />
In 2006, Medoc established the "Medoc <strong>Israel</strong>" division. This division represents companies<br />
world-wide, promoting and distributing their advanced medical solutions to the <strong>Israel</strong>i<br />
market. Medoc Ltd. has developed several strategic collaborations with leading international<br />
suppliers from the USA and Europe including Boston Scientific for treating severe and chronic<br />
pain patients by implanting advanced spinal cord stimulation (SCS) device, Neurotherm for<br />
treatment of local pain by applying Radio Frequency (RF) directly to the pain source, Epimed<br />
for nerve block solutions and catheters and HydroCision for minimal invasive disc-ectomy.<br />
<strong>Technology</strong> and Product(s)<br />
The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced<br />
pain research and fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential<br />
Stimulator) marks a breakthrough in the field of pain-evoked potential, allowing objective<br />
assessment of evoked pain. The PATHWAY model ATS (Advanced Thermal Stimulator)<br />
and PATHWAY model CHEPS are currently used in fMRI studies and in advanced pain<br />
research.<br />
The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to<br />
clinically evaluate small nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory<br />
Sensory Analyzer is used in the assessment of large peripheral nerve fibers (A-beta).<br />
The recently launched Computerized Algometer is a new software-based system, providing<br />
real-time visual and auditory feedback to control and monitor applied pressure rates.<br />
Medoc will launch a series of clinical devices in the coming year to 4 years.<br />
Medoc is also interested in expanding its scope of products in the <strong>Israel</strong>i market by signing<br />
partnership agreements with promising medical device companies offering breakthrough<br />
technology and innovative products.<br />
Goal<br />
Objectives: Looking for representatives / distributors. Medoc is curretnly in the process<br />
of penetrating the clinical market, and seeking potential collaborations with international<br />
companies which are active in the clinical field. Medoc is also interested in expanding<br />
its scope of products (for the <strong>Israel</strong>i market only) and in signing exclusive distribution<br />
agreements with promising medical device companies offering breakthrough technology<br />
and innovative products.<br />
Target Businesses: Distributors; <strong>Medical</strong> devices companies offering breakthrough<br />
technologies; Distributing channels for the clinical field.<br />
Target Countries: Optional<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
42
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Mizra <strong>Medical</strong><br />
www.mizramedical.com<br />
Category:<br />
Disposables and<br />
Implantable<br />
Urology<br />
General Health<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Mizra <strong>Medical</strong> Ltd. developed out of a family business, Mizra Latex Products founded by<br />
Mr. Zeev Mizra in 1955. The company was incorporated as Mizra <strong>Medical</strong> Ltd in 2002 and<br />
the company has grown to be the leading producer of latex disposable products in <strong>Israel</strong>.<br />
Mizra carries a complete line of continence care products and distributes specialized<br />
products that provide solutions to the challenges faced by the elderly, disabled, and others<br />
with special needs.<br />
<strong>Technology</strong> and Product(s)<br />
Mizra <strong>Medical</strong> carries an extensive line of continence care products and distributes<br />
specialized products that provide solutions to the challenges faced by the elderly, disabled,<br />
and others with special needs.<br />
Goal<br />
Objectives: Distribution, Alliances<br />
Target Businesses: Distributors, Hospitals, Pharmacies<br />
Target Countries: Eastern Europe, USA, Canada, <strong>South</strong> America<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
43
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Motorika<br />
www.motorika.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Robotics<br />
Rehabilitation<br />
Neurology and<br />
Degenerative<br />
Diseases<br />
General Health<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Motorika is a leader in manufacturing robot-assisted solutions to meet the therapeutic needs<br />
of patients suffering from a variety of neurological conditions, including stroke, traumatic<br />
brain injury, spinal cord injury, as well as orthopedic and post-surgery dysfunction.<br />
Motorika's products include upper and lower extremities function, providing better<br />
rehabilitation results through a combination of wide variation and intense repetition.<br />
<strong>Technology</strong> and Product(s)<br />
ReoGo is the world’s most advanced robotic system for upper limb therapy, designed to<br />
facilitate three-dimensional repetitive arm movements through the use of an advanced,<br />
fully motorized robotic arm. The system is suited for a wide variety of patients in all stages<br />
of stroke recovery.<br />
ReoAmbulator is a high-end robotic gait training device that integrates Body Weight-<br />
Support Treadmill Training (BWSTT) with advanced robotics to help rehabilitate patients<br />
who experience problems with ambulation, balance, coordination, posture or stamina.<br />
Goal<br />
Objectives: Generate interest from doctors and physiotherapists<br />
Target Businesses: Hospitals, rehabilitation clinics<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
44
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
NanoVibronix<br />
www.nanovibronix.com<br />
Category:<br />
Urology<br />
Wound and Pain<br />
Management<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
NanoVibronix develops innovative medical devices based on its proprietary therapeutic<br />
acoustic technology.<br />
The company two main product lines are for catheter related complications and for<br />
treatment of wounds, soft tissue and pain in a range of clinical applications.<br />
<strong>Technology</strong> and Product(s)<br />
UroShield - prevents biofilm formation on catheters, thereby decreasing risk for urinary<br />
tract infection, increase antibiotic efficacy and decrease pain and discomfort associated<br />
with urinary catheter use.<br />
PainShield - accelerate healing of soft tissue, non-union of fractures and relief of pain.<br />
WoundShield - accelarates wound healing.<br />
Goal<br />
Objectives: Expand distribution network<br />
Target Businesses: Distributors to hospitals, clinics, home-care<br />
Target Countries: Germany, France, Italy, UK, Spain, Scandinavian countries, US and Asia<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
45
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Nava Group<br />
www.navagroup.co.il<br />
Category:<br />
Disposables and<br />
Implantable<br />
General Health<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
We at NAVA GROUP LTD. are in the protective healthcare business since 1970. Nava<br />
Group is among the market leaders in the top grade of quality for absorbent products,<br />
specializing in adult incontinence care. Our main products are adult diapers and bed<br />
pads. Our manufacturing plant is located in Hatzor Haglilit, <strong>Israel</strong>, and we maintain large<br />
warehouse inventories for immediate shipment via our distribution channels.<br />
NAVA GROUP LTD is a private label manufactory. We support our customers on marketing<br />
and consulting. We offer wide range of adults' diapers according to customers'<br />
specifications.<br />
Our products are successfully sold in European and US markets, including TEVA, and are<br />
based on experience of thousands of healthcare providers from around the world. We<br />
provide the highest quality in a modern and unique technology.<br />
Our MISSION is to offer our customers the best value for the money they spend as well<br />
as the assurance that they will provide their clients with the best level of comfort and<br />
security.<br />
<strong>Technology</strong> and Product(s)<br />
• Chlorine-free<br />
• Hypoallergenic<br />
• Latex free<br />
• Fragrance free, neutralized odor technology<br />
• Highest quality SAP<br />
• Supervised controlled forestry for our fluff pulp<br />
• Higher absorbency = using less diapers<br />
• ISO 9001 quality management<br />
Goal<br />
Objectives: Find new private label clients<br />
Target Businesses: Distributors, hospitals, old-age homes, pharmacies<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
46
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Noam Urim Enterprises<br />
www.noam-urim.com<br />
Category:<br />
Disposables and<br />
Implantable<br />
Industrial OEM<br />
General Health<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Noam Urim Enterprises Ltd. is one of the largest non-woven needle punch producers in<br />
the Middle East. Established in 1976 , it supplies various fabrics/substrates for medical<br />
use, including soaped sponge/gloves, antibacterial cleaning cloth, white needle punch for<br />
personal care and cloth for cosmetic applications.<br />
Noam Urim supplies rolled fabrics that serve as raw material. Customers include wet<br />
wipes producers and converters for many other spheres: cosmetics, medical (hospitals,<br />
hotels etc.) and cleaning products.<br />
We can define the perfect fiber blend for any application in all packaging phases – from<br />
big mother rolls to bulk packaging and private label. We produce tailor-made articles and<br />
runs for fast development.<br />
The company is IS0 9001:2000 certified, assuring the highest standard of quality for all<br />
products, which are exported worldwide.<br />
<strong>Technology</strong> and Product(s)<br />
Soaped sponge – gentle soap especially designed for personal healthcare in hospitals<br />
and other health centers. When the sponge makes contact with water, the cleaning agent<br />
is activated. The wipe substrate can be impregnated with almost any soap or detergent –<br />
perfect for practically any purpose. The growing demand for wet wipes and the need for<br />
constant upgrading of the product means increased demand for needle punch material<br />
for dry application.<br />
• Dry version of soaped sponge<br />
• Lightweight<br />
• 2 in 1, replacing need for soap and sponge separately<br />
• Single-use<br />
• Long-lasting<br />
• Many applications: personal care, pet care, general cleaning, car care and more<br />
• Ideal for daily use and sensitive skin<br />
Antibacterial Wipes – provide permanent built-in protection against the growth of<br />
bacteria, mold, fungi and yeast. Long-lasting antibacterial protection does not wash off.<br />
Unique treatment during production ensures wipes are non-allergenic, safe, can be used<br />
longer and are more hygienic.<br />
Cosmetic Dots – wipes containing dots (from gentle to abrasive).<br />
White needle punch - produced in big mother rolls for hygiene, >90 sqm ,min 15cm<br />
width (gloves).<br />
Schedule a Meeting at<br />
Goal<br />
Objectives: Distribution, alliances, customers (converters and private label)<br />
Target Businesses: Hospitals, clinics, cosmetics<br />
Target Countries: Worldwide<br />
Return to Table of Content<br />
47
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
OHK <strong>Medical</strong> Devices<br />
www.hemaclear.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
General Surgery<br />
Disposables and<br />
Implantable<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
The creators of HemaClear® saw the need for a new, different kind of tourniquet, one<br />
that would be simple, safe, sterile, and more cost-effective than any device on the market<br />
today. So they had a vision, and realized it.<br />
HemaClear® is the first and only single-use device that exsanguinates, occludes, and<br />
provides a clearer surgical field. Beginning with a sterile field allows surgeons to place<br />
the device closer to the site than ever before. Its narrower size provides a larger, dryer,<br />
and clearer surgical field, for a better view of anatomical structures. Instant, on-the-spot<br />
sterility, and greater access to the surgical site assures a safer, more successful surgical<br />
outcome. Its innovative technology not only reduces blood loss, infection, and the volume<br />
of ischemic tissue, it’s simplicity saves precious OR set-up time as much as fifteen minutes<br />
and over 100 separate steps that can add as much as $300 to every procedure. In fact,<br />
HemaClear® is so revolutionary, it represents the single greatest advance in tourniquet<br />
technology since the Esmarch bandage.<br />
HemaClear® has been proven worldwide in over 150,000 surgical cases from the OR to<br />
disaster-struck areas all around the world. (The recent earthquake in Haiti).<br />
<strong>Technology</strong> and Product(s)<br />
HemaClear is designed to create a bloodless field for limb surgery, quickly and effectively<br />
without wasting precious time and materials. In the center of the device, a specially<br />
engineered silicone ring exerts just enough circumferential pressure as it rolls up the limb<br />
to exsanguinate completely and occlude the blood vessels - without damaging soft tissue<br />
and nerves.<br />
Factory calibrated and pre-set, HemaClear delivers uniform and reproducible results. Full<br />
range of sizes to accommodate almost every patient type, from pediatric to obese (limb<br />
circumference of 14 to 90 cm).<br />
Goal<br />
Objectives: Develop a distribution network<br />
Target Businesses: Orthopedic surgeons<br />
Target Countries: Germany, Belgium, Holland, Switzerland, Scandinavia<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
48
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Polytex Technologies<br />
www.polytex.co.il<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Polytex Technologies Ltd. provides advance solutions for textile management such as<br />
distribution of uniforms, garments, special wear for clean rooms, operating rooms scrubs,<br />
hotel towels, etc. The Polytex solution is based on unique, patented developments, which<br />
provides the Polytex systems great advantages in terms of speed and reliability of service,<br />
capacity and costs. Our systems are installed at various sites from factories as Intel R&D<br />
center to medical centers like Hadassa <strong>Medical</strong> Center in Jerusalem and Val d'Hebron in<br />
Barcelona.<br />
<strong>Technology</strong> and Product(s)<br />
The Polytex products are divided into textile dispensing units and textile return units for<br />
various applications. all our products are based on a patented technology, developed<br />
by Polytex. The Polytex technology allows our systems to distribute folded items. When<br />
compared to existing solutions in the world, our systems provides the best solution in<br />
terms of speed and reliability in distributing the textile items, speed in loading the items<br />
to the system, very low maintenance needs, high capacity and relatively low costs.<br />
Goal<br />
Objectives: To find potential clients and distributors<br />
Target Businesses: Hospitals, industrial laundries, dealers and distributors of industrial<br />
machinery for laundries, dealers and distributors of hospital logistics systems<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
49
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Q Core <strong>Medical</strong><br />
www.qcore.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Worldwide sales<br />
Company at a Glance<br />
Q Core is the innovation leader in medical infusion delivery systems. A medical device<br />
company totally focused on the medical infusion pump market, Q Core has developed the<br />
most versatile, accurate and reliable infusion pump system platform available. The platform,<br />
based on proprietary, patented technology, delivers multi-therapy and dedicated infusion<br />
pump systems and disposables (sets) for hospital and ambulatory care environments.<br />
Q Core’s infusion pump systems improve drug delivery safety for patients and medical<br />
staff and offer outstanding reliability and low-cost maintenance that together ensure a<br />
low total cost of ownership. The platform is adaptable to changing regulatory and market<br />
requirements, enabling hospitals to be confident of long-term value from their infusion<br />
pump investment.<br />
<strong>Technology</strong> & products<br />
Q Core’s flagship family of Sapphire infusion pump systems provides a comprehensive<br />
answer for medication infusion delivery in hospital and ambulatory care environments.<br />
The Sapphire family stands out in its ability to satisfy a wide range of increasingly challenging<br />
drug delivery needs and its ready adaptability to ever-developing clinical requirements.<br />
The Sapphire large-volume pump provides all the performance, functionality and ease of<br />
use that hospitals require, from critical care settings in hospitals to meeting patient needs<br />
at home. The Sapphire’s low weight and small size free-up overcrowded bedside real<br />
estate and ease patient ambulation.<br />
The Sapphire multi-therapy pump is the flagship product in a line that also includes<br />
dedicated models for TPN, PCA, epidural and drug-specific delivery.<br />
Goals<br />
Target Businesses: Distributors of infusion pumps<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
50
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Shina Systems<br />
www.shina-sys.com<br />
Category:<br />
Telemedicine and<br />
Healthcare IT<br />
Cardiovascular and<br />
Peripheral Vascular<br />
Company Status:<br />
Regulatory Approval<br />
Schedule a Meeting at<br />
Company at a Glance<br />
Shina Systems develops and markets clinical image management and analysis application<br />
software. The company has gained market leadership through its proprietary, automated<br />
image segmentation tools and intuitive, clinician-friendly application workflow. Clinically<br />
effective and technologically distinguished, Shina’s software is installed in thousands of<br />
clinical sites worldwide, either under its own branding, or under the branding of its OEM<br />
partners.<br />
Shina released its first independent advanced (3D/4D) visualization (AV) product to the<br />
market in 2003. CardioCT, the market’s first automated cardiac CT analysis application,<br />
was subsequently licensed to Philips’ CT division.<br />
In 2008, Shina started R&D efforts to develop its next-generation 3Di solution, a new<br />
advanced medical image management and visualization solution aimed at imaging<br />
centers, teleradiology centers and hospitals around the world. The 3Di platform is now<br />
available in cloud-based, client-server and stand-alone workstation deployments allowing<br />
clinicians, healthcare providers, and patients to access 2D/3D medical imaging from<br />
anywhere, whether for clinical analysis of an imaging study or viewing images intuitively<br />
in a personal health record.<br />
<strong>Technology</strong> & Product(s)<br />
3Di Cloud - 3Di is an innovative, cloud-based image management and advanced (3D/4D)<br />
visualization software suite that turns any Internet-connected PC into a comprehensive image<br />
processing workstation. It eliminates costly dedicated storage servers and workstations, while<br />
providing industry-leading interactive image viewing and advanced visualization features.<br />
3Di Enterprise - A PACS server and advanced visualization solution with the server<br />
installed on-site or in a data-center.<br />
3Di Enterprise receives imaging data from DICOM imaging modalities, applies sophisticated<br />
assignment rules and auto-routing to other DICOM systems and then archives them in a<br />
central database system. The system enables management and access to imaging data<br />
through an unlimited number of clients throughout the enterprise network and across<br />
multiple connected sites.<br />
3Di Workstation - An advanced multi-modality viewing and analysis software suite for<br />
Windows PCs. Includes Previewer, a fast 2D/3D multi-modality, multi-monitor review<br />
application, as well as 3Di Viewer, a high-quality full 3D/4D (MPR, MIP, volume rendering<br />
and related techniques) diagnostic viewer, and Cardiac CT analysis tool, CT Colonoscopy,<br />
PET-CT Fusion and others.<br />
Goal<br />
Objectives: To be recognized as the market innovator and a benchmark of excellence for<br />
imaging solutions for all modalities.<br />
Target Businesses:<br />
Dealers\ Distributers of Pacs/Advanced visualization solutions.<br />
Dealers\ Distributers that sale to Radiologists and image centers.<br />
Teleradiology companies.<br />
Imaging centers chains.<br />
Target Countries: All<br />
Return to Table of Content<br />
51
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Sialo <strong>Technology</strong> <strong>Israel</strong><br />
www.sialotechnology.com<br />
Category:<br />
Diagnostics<br />
Disposables and<br />
Implantable<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Sialo <strong>Technology</strong> provides medical solutions for the treatment of salivary gland diseases,<br />
dentistry and other oral conditions and allows physicians to perform minimally invasive<br />
procedures in their clinics. Sialo <strong>Technology</strong> has been granted several international patents<br />
on a range of medical devices.<br />
<strong>Technology</strong> & Product(s)<br />
Sialo <strong>Technology</strong> offers a tiny endoscope to enable vastly improved visibility of the area<br />
under treatment, thereby markedly increasing the success rate of root canal and dental<br />
implant procedures and preventing secondary complications. New innovated dental<br />
implant with internal structure which acts as a drug delivery system.<br />
The Modular Endoscope offered by Sialo <strong>Technology</strong> has very small diameters: 0.59mm<br />
(6,000 pixel, 70° field of view) and 0.93mm (10,000 pixel, 120° field of view - UNIQUE) that<br />
can be used with different size sterile disposable cannulas, solving the decontamination<br />
problem of miniature endoscopes.<br />
Innovative endoscopic technique for root canal and dental implantology moving dentistry<br />
a major step forward.<br />
One endoscope for several procedures. Sterile disposable cannulas used with endoscope<br />
saves on unnecessary sterilization procedure.<br />
Goal<br />
Objectives: Worldwide marketing by cooperation with distributors.<br />
Target Businesses: Worldwide distributors<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
52
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Sion Biotext <strong>Medical</strong><br />
www.sb-medical.com<br />
Category:<br />
Disposables and<br />
Implantable<br />
Cardiovascular and<br />
Peripheral Vascular<br />
Wound and Pain<br />
Management<br />
Infection Control<br />
and Infectious<br />
Diseases<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
Sion Biotext <strong>Medical</strong> Ltd. Is a leading manufacturer of single-use skin cleansing and<br />
treatment, wound care and surgical solutions for the professional health care sector.<br />
The rich product formulations provide additional values, in the cost per unit as well as the<br />
volumes needed for each usage. Sion Biotext medical provide the products in a variety<br />
of package sizes and dispensing options, each one designed to address specific uses and<br />
needs.<br />
Our products are nurse orientated although technology is driving physician interest. We<br />
seek to reduce the cost of healing to the healthcare provider.<br />
The company’s quality system is accredited to ISO 9001, ISO 13485 and GMP regulations.<br />
The products bear the CE mark certification and F.D.A.<br />
<strong>Technology</strong> and Product(s)<br />
Cleansing and Care Line offers a wide range of skin antisepsic products used to minimize<br />
infections caused by skin pathogens, and include:<br />
• Chlorhexidine (0.5%) and Alcohol Prep Pads<br />
• P.V.P Prep Pads and Swabsticks<br />
• Alcohol Prep Pads and Swabsticks<br />
• Lemon Glycerin Swabsticks<br />
• Electrode Skin Prep Pads<br />
• Adhesive Tape Remover Pads<br />
• SkinCoat Prep Pads<br />
Skin Care and Patient Treatment products are delivered in pharmaceutical – grade<br />
bases and serve to protect the skin and maintain optimal skin integrity, and include:<br />
• Sterile Lubrican Jelly<br />
• First Aid Ointments and Creams<br />
• Zinc Oxide, Vitamin AandD Ointment<br />
• Petrolatum Ointment<br />
Wound Care Line combining the traditional bandage and the impregnating technology<br />
resulted in a new age product line:<br />
Zinc/Calamine Paste/bandages for the management of venous leg ulcers and Ice Cool<br />
Elastic Bandages, a revolutionary product designed to deliver cold and compression to the<br />
afected area for treatment of sport injuries bruises, inflamations and sprains.<br />
Surgical Line offers complete solution in the operating theatre by providing products<br />
such as drapes, packs and staff clothing, customised procedure packs/trays.<br />
Schedule a Meeting at<br />
Goal<br />
Objectives: Distribution, alliances<br />
Target Businesses: Clinics, hospitals, home care<br />
Target Countries: Europe, US, Canada, <strong>South</strong> America, Australia<br />
Return to Table of Content<br />
53
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
TavTech<br />
www.tav-tech.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Aesthetics and<br />
Dermatology<br />
Company Status:<br />
Revenue Growth<br />
Company at a Glance<br />
TavTech Ltd. is an innovator of state-of-the-art technology, incorporating jet aviation<br />
principles and engineering. TavTech's unique systems use only natural components -<br />
air (or medical gas) and water - accelerated to supersonic speeds to achieve the desire<br />
effect on tissue. The technology is patented and has broad application across the medical<br />
spectrum.<br />
Aesthetic Medicine and Cosmetology<br />
TavTech's industry-leading exclusive technology brings new dimensions to Aesthetic<br />
Medicine. TavTech's JetPeel systems provide multi-functional skin rejuvenation using<br />
nature's own elements - air, oxygen (or other medical gas) and saline solution. They are<br />
designed for skin rejuvenation, facial resurfacing, removal of age and hyperpigmentation<br />
spots, peri-oral wrinkles, facial deep cleansing (pores, comedones) and moisturizing,<br />
and for use on scars, acne, stretch marks, scalp and a variety of other applications, all<br />
painlessly.<br />
Jet-M that is perfectly positioned to meet the needs of the changing market. Jet-M<br />
provides non-traditional physicians, medspas, and para-medical practitioners, affordable,<br />
multi-function treatment procedures for the aesthetic market. Please visit our website<br />
www.tav-tech.com.<br />
<strong>Technology</strong> and Product(s)<br />
Jet aviation engineering is being used by TavTech to meet the needs of the rapidly<br />
expanding aesthetic, skin care and wound management markets. TavTech's patented<br />
technology creates two-phase jet of micro-droplets consisting of saline solution and gas<br />
(air or medical gas) that is accelerated to velocities that reach 200m/sec., providing a<br />
versatile and precise means for performing a wide variety of skin treatments.<br />
The pressure created by the high-velocity jet stretches the skin at the point of contact,<br />
causing "barophoresis" due to pressure variance; the skin in the high- pressure zone<br />
forms a concave surface and micro-canals in the outer layer of the skin broaden as the<br />
skin stretches and new canals are created. This process facilitates hydration, cleansing and<br />
purifying of the treated area, opens access to the skin's inner layers, allowing for deeper<br />
penetration, and the introduction of vitamins, anti-aging and other solutions.<br />
Goal<br />
Objectives: Identify partners/distributors<br />
Target Businesses: Qualified partners/distributors<br />
Target Countries: Germany, Australia, France<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
54
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Toefix ltd.<br />
www.toefix.co.il<br />
Category:<br />
Disposables and<br />
implantable<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
ToeFIX is an <strong>Israel</strong>i registered company that develops OTC medical devices which replace<br />
common foot surgical procedures. The company has developed a unique and proprietary<br />
treatment for the ingrown toenail problem. The company intends to extend its line of<br />
business with several products in the arena of foot problems treatment, which all replace<br />
surgical interventions.<br />
Toefix operates out of two sites:R&D centre in Haifa, manufacturing and distribution<br />
centre in Taoz, nearby Jerusalem. The company develops, produces and markets innovative<br />
medical devices.<br />
<strong>Technology</strong> & Product(s)<br />
1) Toefix ingrown toenail device got FDA and CE approval (by ISO 13485) and successfully<br />
passed Helsinky human trials with success rate of 93.3% (28 out of 30 patients were<br />
successfully treated with no complications or side effects, while the follow-up for the first<br />
cases is now more than a year), since then many more patients got the treatment provided<br />
by doctors and pedicurists with similar success rate. The device is now in marketing stage<br />
in <strong>Israel</strong> and going to be marketed to Europe and the USA in coming months.<br />
2) A sock for clawtoe(s) and hammertoe(s) gradual repetitive correction, produced in a<br />
variety of techniques and embodiments, having either separate compartments for each<br />
toe or cuts through which a set of restrains might be safely and comfortably anchored<br />
to a pad, positioned over the heel bump (aka Tuber Calcanei) mimicking the direction of<br />
intrinsic muscles pull, and utilizing weight load bearing as a source of corrective force.<br />
Patent has been submitted by the beginning of December 2010.<br />
3) And several more products are available.<br />
Goal<br />
Objectives: Market adaptation, further R&D, sales expansion and strategic partnership<br />
Target Businesses: Pharma chains, <strong>Medical</strong> Practices, <strong>Medical</strong> Device distributors<br />
Target Countries: EU: UK, France, Germany, Netherlands, Italy, Spain, Switzerland;<br />
Eastern Europe; USA; B.R.I.C.S.<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
55
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Ultra Rhino-Therm<br />
www.rhinotherm.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Company Status:<br />
Initial Revenues<br />
Company at a Glance<br />
Established in 2005, privately owned <strong>Israel</strong>i company Ultra Rhino-Therm LTD developed<br />
a medical device to treat patients suffering from nasal congestions. The company is<br />
operating under ISO 13485. Rhinotherm®Ultra’s <strong>Trade</strong> Mark is protected in many countries<br />
worldwide and the device is patented in the USA and pending in other major countries.<br />
<strong>Technology</strong> & Product(s)<br />
Ultra Rhino-Therm LTD offers medical devices for the treat of patients suffering from nasal<br />
congestions associated with the common cold, allergic rhinitis and sinusitis.<br />
Ultra technology is based on the hyperthermia concept, the devices work by delivering<br />
100% water-saturated pressurized air at a temperature of 43˚C (110˚F) directly to the<br />
nasal passages. This quick, effective and drug free treatment offers relief that can last up<br />
to several days<br />
Rhinotherm Ultra® devices are FDA and UL/CE approved devices, and have been subjected<br />
to clinical studies in 10 countries and found to be a safe and effective drug-free source of<br />
relief for symptoms caused by nasal congestion<br />
The original Rhinotherm device was conceived back in 1985, But it was tageted for the<br />
use of medical clinics only, today Rhino-Therm LTD offers a new line of products available<br />
for home use supporting both 110V (UL), 230V (CE).<br />
Goal<br />
Objectives: Locate growth rising and marketing opportunities<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
56
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Vasa Applied Technologies<br />
www.vasa-at.com<br />
Category:<br />
Disposable and<br />
Implantable<br />
Monitoring<br />
Diagnostic<br />
Urology<br />
Company Status:<br />
Pre-Clinical<br />
Company at a Glance<br />
Vasa Applied Technologies Ltd. is a privately-owned <strong>Israel</strong>i start-up company that<br />
developed a patent-pending technology that allows direct flow measurement of secreted<br />
body fluids and low cost devices for growing market niches – breastfeeding and Urology<br />
catheters.<br />
<strong>Technology</strong> and Product(s)<br />
A technology for measuring pulsating low flow rates of fluids excreted and secreted from<br />
the body, based on a patent-pending probe. The probe is easily shaped and integrated in<br />
measuring units, currently implemented in measuring human milk flow and urine flow, for<br />
both hospitals and home environment:<br />
1) The first ever breastfeeding meter - a convenient and simple to operate device that<br />
accurately measures the amount of milk a baby ingests during breastfeeding, for<br />
supporting breastfeeding.<br />
2) Urine flowmeter - an in-line catheter flowmeter that accurately measures the urine<br />
output (flow rate and amount) of a catheterized patient.<br />
Goal<br />
Objectives: Production cooperation; distribution agreements for the two products.<br />
Target Businesses: Distributors, medical device manufacturers for strategic partnership<br />
Target Countries: Worldwide<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
57
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Virtual Ports Ltd.<br />
www.virtual-ports.com<br />
Category:<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
General Surgery<br />
Company Status:<br />
Pre-Clinical<br />
Company at a Glance<br />
Founded in May 2006, Virtual Ports Ltd. is a medical device company focusing on developing<br />
and marketing patented products that improve minimally invasive procedures.<br />
<strong>Technology</strong> & Product(s)<br />
Minimally invasive surgery (MIS) offers patients significant advantages: less pain, fewer<br />
complications, shorter recovery time and smaller scars. However, this notable advance in<br />
medical procedure is often compromised by the disadvantages of manual organ retraction<br />
– an additional port for the grasper and an additional instrument cluttering the operation<br />
site.<br />
EndoGrab - is a groundbreaking internal retractor which is introduced into the abdominal<br />
cavity using a proprietary Applier to expose the operating site by internally anchoring the<br />
organ to the abdomen. After anchoring the organ the Applier is removed, allowing the<br />
port to be re-used for other purposes. During surgery EndoGrab keeps the organ safely<br />
retracted until it can be repositioning or removed once the procedure is completed.<br />
EndoLift – is a groundbreaking internal retractor that lifts the liver and anchors it to<br />
the abdominal wall to expose the underlying organs. EndoLift is hands-free, allowing<br />
surgeons to focus on the task at hand. Furthermore, it does not require anchoring to any<br />
external device that limits the patient’s position and adds clutter to the operating table.<br />
Goal<br />
Objectives: To find potential Distributors<br />
Target Businesses: Distributors in the Laparoscopy field<br />
Target Countries: Europe<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
58
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong>2011<br />
Xenolith <strong>Medical</strong><br />
www.xenolithmedical.com<br />
Category:<br />
Disposables and<br />
implantable<br />
<strong>Medical</strong> and<br />
Hospital Equipment<br />
Urology<br />
Company Status:<br />
Clinical trials<br />
Regulatory<br />
Approval<br />
Company at a Glance<br />
Xenolith <strong>Medical</strong> Ltd is developing medical retention devices for endourologists who wish<br />
to prevent stone migration to the kidney during ureteroscopy procedures. The use of<br />
Xenolith <strong>Medical</strong>’s devices will minimize procedure invasiveness, lower its risk to the patient<br />
and shorten procedure time. Using innovative concepts, our products will replace current<br />
safety guide wires, stone-retrieval baskets and other stone fragment retrieval devices,<br />
thus simplifying the ureteroscopic procedure and reducing overall procedure costs.<br />
The first device that is being developed by Xenolith <strong>Medical</strong>, will change the therapeutic<br />
approach for ureteroscopy, allowing endourologists to perform procedures much easier<br />
and faster than the ones performed today.<br />
<strong>Technology</strong> & Product(s)<br />
The unique approach developed by Xenolith <strong>Medical</strong> incorporates a very thin and flexible<br />
mesh structure as an integral part of a guidewire. The mesh is collapsed into an overlay<br />
tube that forms part of this guide wire and allows it to maintain a very slim (less than<br />
1mm) profile. Xenolith <strong>Medical</strong>’s device also has a flexible floppy tip that can be advanced<br />
past urethral stones. Much like a guidewire, Xenolith <strong>Medical</strong>’s device can be used either<br />
side-by-side to the ureteroscope or introduced through its working channel. Upon ureter<br />
introduction the device is advanced beyond the occluding stone until reaches the kidney<br />
so the mesh is positioned proximal to the stone (i.e. between the stone and the kidney).<br />
Once properly positioned, the overlay tube that retracts the mesh is withdrawn, allowing<br />
the mesh to deploy and self-expand. The mesh can self-expand up to 12mm in diameter,<br />
fitting to all ureter sizes and shapes applying a carefully pre-calibrated radial force to<br />
the ureter wall. The fully deployed mesh acts as a barrier to particles larger than 1mm<br />
preventing their migration to the kidney and allowing enhanced irrigation for both better<br />
visualization and faster lithotripsy due to stone migration prevention.<br />
Goal<br />
Objectives: Meetings with distributors and strategic partners<br />
Target Businesses: Strategic partners<br />
Target Countries: Europe<br />
Schedule a Meeting at<br />
Return to Table of Content<br />
59
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Schedule a Meeting<br />
Contact our commercial attaches around the world at:<br />
<strong>South</strong> Europe and<br />
Africa<br />
North Europe<br />
Central and East<br />
Europe<br />
Paris, France<br />
(+33.1)4076-5560<br />
paris@israeltrade.gov.il<br />
Brussels, Belgium<br />
(+32.2) 3735-533/4/5<br />
brussels@israeltrade.gov.il<br />
Vienna, Austria<br />
(+43.1) 4764-6516<br />
vienna@israeltrade.gov.il<br />
Milan, Italy<br />
(+390.2) 7601-5545<br />
milano@israeltrade.gov.il<br />
London, UK<br />
(+44.207) 9579-525<br />
london@israeltrade.gov.il<br />
Warsaw, Poland<br />
(48.22+) 5970-514<br />
warsaw@israeltrade.gov.il<br />
Madrid, Spain<br />
(+34.91) 782-9520/9<br />
madrid@israeltrade.gov.il<br />
Berlin, Germany<br />
(+49.30) 2064-490<br />
berlin@israeltrade.gov.il<br />
Bucharest, Romania<br />
(+40.21) 3189-407/8<br />
bucharest@israeltrade.gov.il<br />
Johannesburg, <strong>South</strong> Africa<br />
(+27.11) 7839-605<br />
johannesburg@israeltrade.gov.il<br />
Hague, Netherlands<br />
(+31.70) 3760-514<br />
hague@israeltrade.gov.il<br />
Moscow, Russia<br />
(+7.495) 7972-737/9<br />
moscow@israeltrade.gov.il<br />
Istanbul, Turkey<br />
(+90.212) 3176-547<br />
istanbul@israeltrade.gov.il<br />
Stockholm, Sweden<br />
(+46.8) 5280-6580<br />
stockholm@israeltrade.gov.il<br />
Geneva, Switzerland<br />
(+41.22) 7160-507<br />
geneva@israeltrade.gov.il<br />
Kiev, Ukraine<br />
(+380) 44-5861-552/3<br />
kiev@israeltrade.gov.il<br />
Return to Table of Content<br />
60
<strong>Israel</strong> <strong>Medical</strong> <strong>Innovation</strong><br />
2011<br />
Schedule a Meeting<br />
Contact our commercial attaches around the world at:<br />
North and <strong>South</strong><br />
America<br />
Asia and Pacific<br />
India and China<br />
Sao Paolo, Brazil<br />
(+55.11) 3032-3511<br />
saopaolo@israeltrade.gov.il<br />
Sydney, Australia<br />
(+61.2) 93880-382<br />
sydney@israeltrade.gov.il<br />
Beijing, China<br />
(+86.10) 8532-0664<br />
beijing@israeltrade.gov.il<br />
Toronto, Canada<br />
(+1.416) 6408-540/1<br />
Toronto@israeltrade.gov.il<br />
Tokyo, Japan<br />
(+81.3) 3264-0398<br />
tokyo@israeltrade.gov.il<br />
Guangzhou, China<br />
(+86. 20) 8513-0518/9<br />
guangzhou@israeltrade.gov.il<br />
Mexico City, Mexico<br />
(+52.55) 5201-1511<br />
mexico@israeltrade.gov.il<br />
Seoul, <strong>South</strong> Korea<br />
(+82.2) 723-6121/2<br />
korea@israeltrade.gov.il<br />
Delhi, India<br />
(+91.11) 3041-4518<br />
delhi@israeltrade.gov.il<br />
Washington, USA<br />
(+1-202) 364-5695<br />
washington@israeltrade.gov.il<br />
Singapore<br />
(+65) 68-349-220<br />
singapore@israeltrade.gov.il<br />
Mumbai, India<br />
(+91.22) 2202-4643<br />
mumbai@israeltrade.gov.il<br />
Chicago, USA<br />
(+1.312) 3322-160<br />
chicago@israeltrade.gov.il<br />
Taipei, Taiwan<br />
(+886.2) 2757-7221/2<br />
Taipei@israeltrade.gov.il<br />
Houston, USA<br />
(+1.713) 5990-290<br />
houston@israeltrade.gov.il<br />
Bangkok, Thailand<br />
(+66.2)2049-240/1<br />
bangkok@israeltrade.gov.il<br />
Los Angeles, USA<br />
(+1.323) 6587-924<br />
losangeles@israeltrade.gov.il<br />
Hanoi, Vietnam<br />
(+84.43) 843-3140<br />
vietnam@israeltrade.gov.il<br />
New York, USA<br />
(+1.212) 4995-610<br />
newyork@israeltrade.gov.il<br />
Return to Table of Content<br />
61
Change language